{
  "$schema": "folio-library-document/v1",
  "id": "10665-44118",
  "title": "Casebook on ethical issues in international health research / edited by Richard Cash [... et al]",
  "variant": "pdf",
  "pages": 212,
  "tocSource": "inferred",
  "tocMethod": "contents",
  "toc": [
    {
      "level": 1,
      "title": "Acknowledgements",
      "number": null,
      "page": 10,
      "pageLabel": "8",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-000-acknowledgements"
    },
    {
      "level": 1,
      "title": "Foreword",
      "number": null,
      "page": 11,
      "pageLabel": "9",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-001-foreword"
    },
    {
      "level": 1,
      "title": "The editors",
      "number": null,
      "page": 12,
      "pageLabel": "10",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-002-the-editors"
    },
    {
      "level": 1,
      "title": "Introduction",
      "number": null,
      "page": 13,
      "pageLabel": "11",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-003-introduction"
    },
    {
      "level": 1,
      "title": "Teaching Guide",
      "number": null,
      "page": 17,
      "pageLabel": "15",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-004-teaching-guide"
    },
    {
      "level": 1,
      "title": "The Case Studies",
      "number": null,
      "page": 37,
      "pageLabel": "35",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-005-the-case-studies"
    },
    {
      "level": 1,
      "title": "Chapter I Defining “Research”",
      "number": null,
      "page": 39,
      "pageLabel": "37",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-006-chapter-i-defining-research"
    },
    {
      "level": 2,
      "title": "Case 1. SARS and airplane passengers",
      "number": null,
      "page": 44,
      "pageLabel": "42",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-007-case-1-sars-and-airplane-passengers"
    },
    {
      "level": 2,
      "title": "Case 2. Evaluating sexual health and family planning programmes",
      "number": null,
      "page": 45,
      "pageLabel": "43",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-008-case-2-evaluating-sexual-health-and-family-plann"
    },
    {
      "level": 2,
      "title": "Case 3. A treatment for central nervous system conditions",
      "number": null,
      "page": 46,
      "pageLabel": "44",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-009-case-3-a-treatment-for-central-nervous-system-co"
    },
    {
      "level": 2,
      "title": "Case 4. Documenting the health conditions of an indigenous community",
      "number": null,
      "page": 47,
      "pageLabel": "45",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-010-case-4-documenting-the-health-conditions-of-an-i"
    },
    {
      "level": 1,
      "title": "Chapter II Issues in Study Design",
      "number": null,
      "page": 49,
      "pageLabel": "47",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-011-chapter-ii-issues-in-study-design"
    },
    {
      "level": 2,
      "title": "Case 5. Referral of severely ill children to hospital",
      "number": null,
      "page": 57,
      "pageLabel": "55",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-012-case-5-referral-of-severely-ill-children-to-hosp"
    },
    {
      "level": 2,
      "title": "Case 6. Negotiating safe sex practices",
      "number": null,
      "page": 58,
      "pageLabel": "56",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-013-case-6-negotiating-safe-sex-practices"
    },
    {
      "level": 2,
      "title": "Case 7. Investigating treatment recommendations",
      "number": null,
      "page": 59,
      "pageLabel": "57",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-014-case-7-investigating-treatment-recommendations"
    },
    {
      "level": 2,
      "title": "Case 8. Testing a new HBV vaccine",
      "number": null,
      "page": 60,
      "pageLabel": "58",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-015-case-8-testing-a-new-hbv-vaccine"
    },
    {
      "level": 2,
      "title": "Case 9. Tuberculosis prevention in HIV-positive people",
      "number": null,
      "page": 61,
      "pageLabel": "59",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-016-case-9-tuberculosis-prevention-in-hiv-positive-p"
    },
    {
      "level": 2,
      "title": "Case 10. Developing a vaccine for malaria",
      "number": null,
      "page": 62,
      "pageLabel": "60",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-017-case-10-developing-a-vaccine-for-malaria"
    },
    {
      "level": 2,
      "title": "Case 11. Should race be listed as a risk factor?",
      "number": null,
      "page": 64,
      "pageLabel": "62",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-018-case-11-should-race-be-listed-as-a-risk-factor"
    },
    {
      "level": 2,
      "title": "Case 12. Short-course AZT to prevent mother-to-child transmission of HIV",
      "number": null,
      "page": 65,
      "pageLabel": "63",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-019-case-12-short-course-azt-to-prevent-mother-to-ch"
    },
    {
      "level": 2,
      "title": "Case 13. Testing an ayurvedic medicine for malaria",
      "number": null,
      "page": 67,
      "pageLabel": "65",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-020-case-13-testing-an-ayurvedic-medicine-for-malari"
    },
    {
      "level": 2,
      "title": "Case 14. Evaluating the use of traditional medicines for diarrhoea",
      "number": null,
      "page": 69,
      "pageLabel": "67",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-021-case-14-evaluating-the-use-of-traditional-medici"
    },
    {
      "level": 2,
      "title": "Case 15. Twin registry genetics",
      "number": null,
      "page": 70,
      "pageLabel": "68",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-022-case-15-twin-registry-genetics"
    },
    {
      "level": 2,
      "title": "Case 16. Observing newborn care practices",
      "number": null,
      "page": 71,
      "pageLabel": "69",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-023-case-16-observing-newborn-care-practices"
    },
    {
      "level": 2,
      "title": "Case 17. Compassionate intervention during an observational study",
      "number": null,
      "page": 72,
      "pageLabel": "70",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-024-case-17-compassionate-intervention-during-an-obs"
    },
    {
      "level": 1,
      "title": "Chapter III Harm and Benefit",
      "number": null,
      "page": 73,
      "pageLabel": "71",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-025-chapter-iii-harm-and-benefit"
    },
    {
      "level": 2,
      "title": "Case 18. Rotavirus vaccine",
      "number": null,
      "page": 78,
      "pageLabel": "76",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": "sec-026-case-18-rotavirus-vaccine"
    },
    {
      "level": 2,
      "title": "Case 19. Pneumonia vaccine trial",
      "number": null,
      "page": 80,
      "pageLabel": "78",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-027-case-19-pneumonia-vaccine-trial"
    },
    {
      "level": 2,
      "title": "Case 20. Early termination of a trial",
      "number": null,
      "page": 81,
      "pageLabel": "79",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-028-case-20-early-termination-of-a-trial"
    },
    {
      "level": 2,
      "title": "Case 21. Pregnancy in health research",
      "number": null,
      "page": 82,
      "pageLabel": "80",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-029-case-21-pregnancy-in-health-research"
    },
    {
      "level": 2,
      "title": "Case 22. Acting in the face of conflicting evidence",
      "number": null,
      "page": 83,
      "pageLabel": "81",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-030-case-22-acting-in-the-face-of-conflicting-eviden"
    },
    {
      "level": 1,
      "title": "Chapter IV Voluntary Informed Consent",
      "number": null,
      "page": 85,
      "pageLabel": "83",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-031-chapter-iv-voluntary-informed-consent"
    },
    {
      "level": 2,
      "title": "Case 23. Testing high doses of vitamin A on children",
      "number": null,
      "page": 94,
      "pageLabel": "92",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-032-case-23-testing-high-doses-of-vitamin-a-on-child"
    },
    {
      "level": 2,
      "title": "Case 24. Breast cancer in South Asia",
      "number": null,
      "page": 95,
      "pageLabel": "93",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-033-case-24-breast-cancer-in-south-asia"
    },
    {
      "level": 2,
      "title": "Case 25. Testing a microbicide",
      "number": null,
      "page": 97,
      "pageLabel": "95",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-034-case-25-testing-a-microbicide"
    },
    {
      "level": 2,
      "title": "Case 26. A study to determine the value of postoperative radiotherapy",
      "number": null,
      "page": 99,
      "pageLabel": "97",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-035-case-26-a-study-to-determine-the-value-of-postop"
    },
    {
      "level": 2,
      "title": "Case 27. Micronutrient supplementation for pregnant women",
      "number": null,
      "page": 100,
      "pageLabel": "98",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-036-case-27-micronutrient-supplementation-for-pregna"
    },
    {
      "level": 2,
      "title": "Case 28. Breastfeeding and mother-to-child HIV transmission",
      "number": null,
      "page": 102,
      "pageLabel": "100",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-037-case-28-breastfeeding-and-mother-to-child-hiv-tr"
    },
    {
      "level": 2,
      "title": "Case 29. Humanized mice",
      "number": null,
      "page": 104,
      "pageLabel": "102",
      "confidence": 0.5,
      "evidence": [
        "contents"
      ],
      "source": "inferred",
      "section": "sec-038-case-29-humanized-mice"
    },
    {
      "level": 2,
      "title": "Case 30. Donations for stem-cell research",
      "number": null,
      "page": 105,
      "pageLabel": "103",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-039-case-30-donations-for-stem-cell-research"
    },
    {
      "level": 2,
      "title": "Case 31. Researching health care practices and needs in an elderly population",
      "number": null,
      "page": 106,
      "pageLabel": "104",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-040-case-31-researching-health-care-practices-and-ne"
    },
    {
      "level": 1,
      "title": "Chapter V Standard of Care",
      "number": null,
      "page": 107,
      "pageLabel": "105",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-041-chapter-v-standard-of-care"
    },
    {
      "level": 2,
      "title": "Case 32. Testing a new HIV vaccine",
      "number": null,
      "page": 112,
      "pageLabel": "110",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-042-case-32-testing-a-new-hiv-vaccine"
    },
    {
      "level": 2,
      "title": "Case 33. Short-course antiretroviral therapy in pregnant women",
      "number": null,
      "page": 114,
      "pageLabel": "112",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-043-case-33-short-course-antiretroviral-therapy-in-p"
    },
    {
      "level": 2,
      "title": "Case 34. Use of quinacrine for non-surgical sterilization",
      "number": null,
      "page": 115,
      "pageLabel": "113",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-044-case-34-use-of-quinacrine-for-non-surgical-steri"
    },
    {
      "level": 2,
      "title": "Case 35. Investigation of vaginal microbicides",
      "number": null,
      "page": 117,
      "pageLabel": "115",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-045-case-35-investigation-of-vaginal-microbicides"
    },
    {
      "level": 1,
      "title": "Chapter VI Obligations to Participants and Communities",
      "number": null,
      "page": 119,
      "pageLabel": "117",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-046-chapter-vi-obligations-to-participants-and-commu"
    },
    {
      "level": 2,
      "title": "Case 36. Observational study of cervical cancer",
      "number": null,
      "page": 126,
      "pageLabel": "124",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-047-case-36-observational-study-of-cervical-cancer"
    },
    {
      "level": 2,
      "title": "Case 37. Testing a malaria vaccine",
      "number": null,
      "page": 128,
      "pageLabel": "126",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-048-case-37-testing-a-malaria-vaccine"
    },
    {
      "level": 2,
      "title": "Case 38. Mental health problems of survivors of mass violence",
      "number": null,
      "page": 130,
      "pageLabel": "128",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-049-case-38-mental-health-problems-of-survivors-of-m"
    },
    {
      "level": 2,
      "title": "Case 39. A longitudinal study of rotavirus incidence among young children",
      "number": null,
      "page": 132,
      "pageLabel": "130",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-050-case-39-a-longitudinal-study-of-rotavirus-incide"
    },
    {
      "level": 2,
      "title": "Case 40. Testing a vaccine for childhood cholera",
      "number": null,
      "page": 134,
      "pageLabel": "132",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-051-case-40-testing-a-vaccine-for-childhood-cholera"
    },
    {
      "level": 2,
      "title": "Case 41. Impact of civil war on health systems",
      "number": null,
      "page": 135,
      "pageLabel": "133",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-052-case-41-impact-of-civil-war-on-health-systems"
    },
    {
      "level": 2,
      "title": "Case 42. Determining who constitutes the community",
      "number": null,
      "page": 136,
      "pageLabel": "134",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-053-case-42-determining-who-constitutes-the-communit"
    },
    {
      "level": 2,
      "title": "Case 43. Evaluation research on a disability rehabilitation programme",
      "number": null,
      "page": 138,
      "pageLabel": "136",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-054-case-43-evaluation-research-on-a-disability-reha"
    },
    {
      "level": 2,
      "title": "Case 44. Clinical benefits of an immune-modifying supplement in HIV therapy",
      "number": null,
      "page": 140,
      "pageLabel": "138",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-055-case-44-clinical-benefits-of-an-immune-modifying"
    },
    {
      "level": 2,
      "title": "Case 45. Genetic research on an island population",
      "number": null,
      "page": 141,
      "pageLabel": "139",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-056-case-45-genetic-research-on-an-island-population"
    },
    {
      "level": 1,
      "title": "Chapter VII Privacy and Confidentiality",
      "number": null,
      "page": 143,
      "pageLabel": "141",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-057-chapter-vii-privacy-and-confidentiality"
    },
    {
      "level": 2,
      "title": "Case 46. Studying Nevirapine in West Africa",
      "number": null,
      "page": 148,
      "pageLabel": "146",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-058-case-46-studying-nevirapine-in-west-africa"
    },
    {
      "level": 2,
      "title": "Case 47. The quality of care in a family welfare programme",
      "number": null,
      "page": 149,
      "pageLabel": "147",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-059-case-47-the-quality-of-care-in-a-family-welfare"
    },
    {
      "level": 2,
      "title": "Case 48. Responding when study findings are challenged",
      "number": null,
      "page": 150,
      "pageLabel": "148",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-060-case-48-responding-when-study-findings-are-chall"
    },
    {
      "level": 2,
      "title": "Case 49. Determining post-abortion complication levels",
      "number": null,
      "page": 151,
      "pageLabel": "149",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-061-case-49-determining-post-abortion-complication-l"
    },
    {
      "level": 2,
      "title": "Case 50. Evaluating the cost-benefit ratio of long-term care services",
      "number": null,
      "page": 153,
      "pageLabel": "151",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-062-case-50-evaluating-the-cost-benefit-ratio-of-lon"
    },
    {
      "level": 2,
      "title": "Case 51. Research on an identifiable population",
      "number": null,
      "page": 154,
      "pageLabel": "152",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-063-case-51-research-on-an-identifiable-population"
    },
    {
      "level": 2,
      "title": "Case 52. Case-control study of vasectomy and prostate cancer",
      "number": null,
      "page": 155,
      "pageLabel": "153",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-064-case-52-case-control-study-of-vasectomy-and-pros"
    },
    {
      "level": 2,
      "title": "Case 53. Studying health-seeking behaviour",
      "number": null,
      "page": 156,
      "pageLabel": "154",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-065-case-53-studying-health-seeking-behaviour"
    },
    {
      "level": 2,
      "title": "Case 54. Health promotion survey research on a commercial farm",
      "number": null,
      "page": 157,
      "pageLabel": "155",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-066-case-54-health-promotion-survey-research-on-a-co"
    },
    {
      "level": 2,
      "title": "Case 55. Interviewing child domestic helpers in sub-Saharan Africa",
      "number": null,
      "page": 159,
      "pageLabel": "157",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-067-case-55-interviewing-child-domestic-helpers-in-s"
    },
    {
      "level": 1,
      "title": "Chapter VIII Professional Ethics",
      "number": null,
      "page": 161,
      "pageLabel": "159",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-068-chapter-viii-professional-ethics"
    },
    {
      "level": 2,
      "title": "Case 56. Testing delivery methods for a hormonal contraceptive",
      "number": null,
      "page": 167,
      "pageLabel": "165",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-069-case-56-testing-delivery-methods-for-a-hormonal"
    },
    {
      "level": 2,
      "title": "Case 57. Testing a treatment for schizophrenia",
      "number": null,
      "page": 168,
      "pageLabel": "166",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-070-case-57-testing-a-treatment-for-schizophrenia"
    },
    {
      "level": 2,
      "title": "Case 58. Budget reviews by research ethics committees",
      "number": null,
      "page": 169,
      "pageLabel": "167",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-071-case-58-budget-reviews-by-research-ethics-commit"
    },
    {
      "level": 2,
      "title": "Case 59. Determining the workforce costs of the AIDS epidemic",
      "number": null,
      "page": 170,
      "pageLabel": "168",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-072-case-59-determining-the-workforce-costs-of-the-a"
    },
    {
      "level": 2,
      "title": "Case 60. Action research on involuntary resettlement",
      "number": null,
      "page": 172,
      "pageLabel": "170",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-073-case-60-action-research-on-involuntary-resettlem"
    },
    {
      "level": 2,
      "title": "Case 61. Victimizing the system or a victim of it?",
      "number": null,
      "page": 174,
      "pageLabel": "172",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-074-case-61-victimizing-the-system-or-a-victim-of-it"
    },
    {
      "level": 2,
      "title": "Case 62. Truth and consequences",
      "number": null,
      "page": 176,
      "pageLabel": "174",
      "confidence": 0.75,
      "evidence": [
        "contents",
        "body"
      ],
      "source": "inferred",
      "section": "sec-075-case-62-truth-and-consequences"
    },
    {
      "level": 2,
      "title": "Case 63. The curious career of Dr Taylor",
      "number": null,
      "page": 177,
      "pageLabel": "175",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-076-case-63-the-curious-career-of-dr-taylor"
    },
    {
      "level": 2,
      "title": "Case 64. Whose idea is it, anyway?",
      "number": null,
      "page": 179,
      "pageLabel": "177",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-077-case-64-whose-idea-is-it-anyway"
    },
    {
      "level": 1,
      "title": "Glossary",
      "number": null,
      "page": 181,
      "pageLabel": "179",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-078-glossary"
    },
    {
      "level": 1,
      "title": "Suggested readings and resources",
      "number": null,
      "page": 195,
      "pageLabel": "193",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-079-suggested-readings-and-resources"
    },
    {
      "level": 1,
      "title": "Appendix",
      "number": null,
      "page": 210,
      "pageLabel": "208",
      "confidence": 0.9,
      "evidence": [
        "contents",
        "body",
        "style"
      ],
      "source": "inferred",
      "section": "sec-080-appendix"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 10,
      "labelStart": null,
      "labelEnd": "8",
      "words": 1515,
      "summary": {
        "text": "Front matter of the WHO Casebook on Ethical Issues in International Health Research (2009), giving the title, the four editors and the associate editor, cataloguing data with the ISBN, and the copyright and disclaimer notice. A short note explains that the casebook is meant for instructors and workshop leaders, who may photocopy or download individual cases for non-commercial teaching as long as WHO is acknowledged. The table of contents then lists the introductory sections, the 64 case studies grouped into thematic chapters, a glossary, suggested readings and an appendix.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "airplane passengers",
          "heading": false
        },
        {
          "term": "malaria vaccine",
          "heading": false
        },
        {
          "term": "abha saxena",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "richard cash",
          "heading": false
        },
        {
          "term": "hbv vaccine",
          "heading": false
        },
        {
          "term": "case studies",
          "heading": false
        },
        {
          "term": "daniel wikler",
          "heading": false
        }
      ],
      "extract": "Casebook on Ethical Issues in International Health Research Editors: Richard Cash Daniel Wikler Abha Saxena Alexander Capron Casebook on Ethical Issues in International Health Research Editors: Richard Cash Daniel Wikler Abha Saxena Alexander Capron Associate editor: Reva Gutnick Editorial guidance provided by Astrid Stuckelberger and Philippe Chastonay, University of Geneva CASEBOOK ON ETHICAL ISSUES IN",
      "extractCut": true,
      "blocks": [
        "library/10665-44118/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-acknowledgements",
      "number": null,
      "title": "Acknowledgements",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 11,
      "labelStart": "8",
      "labelEnd": "9",
      "words": 716,
      "summary": {
        "text": "Acknowledgements for the casebook, which grew out of a Research Ethics Training Project between WHO and the University of Geneva funded by the Geneva International Academic Network (RUIG/GIAN). The editors thank the people who proposed or wrote case studies, including teams from Johns Hopkins University, the Sri Lanka Twin Registry and a 2004 Bangkok workshop of the special programme on human reproduction. They also credit workshop facilitators, online course tutors, international reviewers, editorial interns and the designers, and sign the text in March 2009.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "astrid stuckelberger",
          "heading": false
        },
        {
          "term": "ruig gian",
          "heading": false
        },
        {
          "term": "nancy kass",
          "heading": false
        },
        {
          "term": "susan bull",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "case studies",
          "heading": false
        },
        {
          "term": "johns hopkins",
          "heading": false
        },
        {
          "term": "casebook",
          "heading": false
        }
      ],
      "extract": "This casebook is the result of a collaborative effort titled “the Research Ethics Training Project” between the World Health Organization and the University of Geneva undertaken with the generous financial support of Réseau universitaire international de Genève/Geneva International Academic Network (RUIG/GIAN). Many people have shared their time, energy and expertise in the development of this casebook. Philippe",
      "extractCut": true
    },
    {
      "id": "sec-001-foreword",
      "number": null,
      "title": "Foreword",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 12,
      "labelStart": "9",
      "labelEnd": "10",
      "words": 430,
      "summary": {
        "text": "The foreword, by WHO Assistant Director-General Timothy Evans, states that sound ethical standards are an essential part of health research and that WHO is stepping up efforts to ensure they are met, especially in resource-poor settings where local researchers and ethics committees must be able to recognise and handle ethical issues. It explains that the casebook, developed under the lead of WHO's Ethics Review Committee, uses cases based on real studies for individual reading or group discussion as an effective way to learn to apply ethical principles.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "ethical standards",
          "heading": false
        },
        {
          "term": "foreword",
          "heading": true
        },
        {
          "term": "international health",
          "heading": false
        },
        {
          "term": "review committee",
          "heading": false
        },
        {
          "term": "ethics",
          "heading": false
        },
        {
          "term": "casebook",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH For the World Health Organization, research is a vital ingredi- ent for improved global health. Our dedication to producing and using knowledge to improve human health is itself grounded on an ethical commitment: that such research is carried out ethically and offers the prospect of raising the standard of health for everyone. One of the essential",
      "extractCut": true
    },
    {
      "id": "sec-002-the-editors",
      "number": null,
      "title": "The editors",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 13,
      "labelStart": "10",
      "labelEnd": "11",
      "words": 551,
      "summary": {
        "text": "Gives short biographies of the four editors: Richard Cash and Daniel Wikler of the Harvard School of Public Health, Abha Saxena, who manages the WHO Research Ethics Review Committee, and Alex Capron of the University of Southern California. It highlights their research, teaching and leadership roles in global health and bioethics, including Cash's early oral rehydration therapy trials and the former WHO ethics posts held by Wikler and Capron.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "prof",
          "heading": false
        },
        {
          "term": "public health",
          "heading": false
        },
        {
          "term": "global health",
          "heading": false
        },
        {
          "term": "world health",
          "heading": false
        },
        {
          "term": "president",
          "heading": false
        }
      ],
      "extract": "Richard A. Cash MD, MPH, is a Senior Lecturer in the Department of Global Health and Population at the Harvard School of Public Health (HSPH). He is the Director of the Program on Ethical Issues in Global Health Research at HSPH. Dr Cash has been involved in international health for over 40 years as a researcher, a funder and developer of health research projects, and as a visiting faculty at a number of schools of",
      "extractCut": true
    },
    {
      "id": "sec-003-introduction",
      "number": null,
      "title": "Introduction",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 17,
      "labelStart": "11",
      "labelEnd": "15",
      "words": 1092,
      "summary": {
        "text": "Introduces the casebook's 64 case studies, each built around one or two ethical problems in planning, reviewing or conducting health research, and intended mainly for teaching researchers and research ethics committee members, especially in international settings. The cases are short, grouped by main issue and drawn from real projects, with names, dates and places changed so that readers concentrate on the dilemmas. It also explains WHO's reasons for the book, including the educational work of its Research Ethics Review Committee and the case-based workshops held with the Harvard School of Public Health since 1999, which found that discussing cases helps limit cultural bias and leads to concrete responses.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "erc secretariat",
          "heading": false
        },
        {
          "term": "research projects",
          "heading": false
        },
        {
          "term": "reviewing research",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "nongovern mental",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "ethi cal",
          "heading": false
        }
      ],
      "extract": "© who/ Photolibrary 12 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH This casebook collects 64 case studies, each of which raises an important and difficult ethical issue connected with planning, reviewing, or conducting health-related research. The book’s purpose is to contribute to thoughtful analysis of these issues by researchers and members of research ethics committees (RECs, known in some places",
      "extractCut": true
    },
    {
      "id": "sec-004-teaching-guide",
      "number": null,
      "title": "Teaching Guide",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 37,
      "labelStart": "15",
      "labelEnd": "35",
      "words": 10690,
      "summary": {
        "text": "A teaching guide for facilitators who use the casebook in courses and workshops on research ethics. It first covers the method of case-based teaching, stressing the facilitator's role in guiding active discussion among participants and remaining open to cases with no single right answer instead of steering towards a preferred conclusion. It then reviews the main issues raised in each chapter and suggests discussion questions, ending with themes such as how scientific misconduct should be defined, judged and reported. A short list of further resources on teaching with case studies closes the section.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "teaching guide",
          "heading": true
        },
        {
          "term": "case-based teaching",
          "heading": false
        },
        {
          "term": "teaching case",
          "heading": false
        },
        {
          "term": "ethical research",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "workshop participants",
          "heading": false
        }
      ],
      "extract": "© WHO/TDR/Crump 16 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH This brief teaching guide is intended as an aide to those using these case studies in their teaching or training workshops. The guide first addresses the process of teaching case studies. Case-based teaching differs significantly from traditional lectures and, therefore, requires a different approach and additional skills. Because",
      "extractCut": true
    },
    {
      "id": "sec-005-the-case-studies",
      "number": null,
      "title": "The Case Studies",
      "level": 1,
      "pageStart": 37,
      "pageEnd": 39,
      "labelStart": "35",
      "labelEnd": "37",
      "words": 0,
      "summary": null,
      "keywords": [],
      "extract": null,
      "extractCut": false
    },
    {
      "id": "sec-006-chapter-i-defining-research",
      "number": null,
      "title": "Chapter I Defining “Research”",
      "level": 1,
      "pageStart": 39,
      "pageEnd": 44,
      "labelStart": "37",
      "labelEnd": "42",
      "words": 2593,
      "summary": {
        "text": "Opens Chapter I, which asks what counts as 'research' and therefore when a research ethics committee's approval must be sought. It separates research, whose main purpose is to produce new knowledge, from medical treatment meant to benefit an individual patient and from activities such as surveillance, audit or quality improvement. The introduction warns that the pursuit of knowledge must not outweigh participants' welfare, recalling the Nazi experiments and noting risks such as the therapeutic misconception and harms from sensitive social research. It closes with suggested readings, including CDC guidance on telling public health research from non-research and an article on distinguishing audit from research.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "research",
          "heading": true
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "ethics committees",
          "heading": false
        },
        {
          "term": "research studies",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "operations research",
          "heading": false
        },
        {
          "term": "studies deﬁning",
          "heading": false
        }
      ],
      "extract": "Defining “Research” © WHO/Pierre Virot 38 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH The need for a definition of ‘research,’ for the purposes of ethi- cal review, is closely related to a practical decision: what kinds of activities should be subject to review by a research ethics committee (REC)? But defining what is meant by ‘research’ involves matters of principle not just management. The case",
      "extractCut": true
    },
    {
      "id": "sec-007-case-1-sars-and-airplane-passengers",
      "number": null,
      "title": "Case 1. SARS and airplane passengers",
      "level": 2,
      "pageStart": 44,
      "pageEnd": 45,
      "labelStart": "42",
      "labelEnd": "43",
      "words": 468,
      "summary": {
        "text": "Case 1 describes a national public health centre that, during the 2003 SARS outbreak, traced airline passengers who had flown with suspected cases and asked for blood samples and medical histories from healthy travellers, even though delays meant testing came after the likely incubation period. It asks whether the data were collected for surveillance, disease prevention or research, and whether ethics committee approval and informed consent were needed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "sars",
          "heading": true
        },
        {
          "term": "flight manifest",
          "heading": false
        },
        {
          "term": "passengers",
          "heading": true
        },
        {
          "term": "sars cases",
          "heading": false
        },
        {
          "term": "airplane",
          "heading": true
        },
        {
          "term": "incubation period",
          "heading": false
        },
        {
          "term": "national centre",
          "heading": false
        },
        {
          "term": "index case",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH In Country X, public health responsibilities are lodged in a national centre which carries out routine surveillance of diseases in association with local health agencies, and disseminates information as an aid to disease control and prevention. In March 2003, during the worldwide outbreak of a new human pathogen labelled severe acute respiratory syndrome",
      "extractCut": true
    },
    {
      "id": "sec-008-case-2-evaluating-sexual-health-and-family-plann",
      "number": null,
      "title": "Case 2. Evaluating sexual health and family planning programmes",
      "level": 2,
      "pageStart": 45,
      "pageEnd": 46,
      "labelStart": "43",
      "labelEnd": "44",
      "words": 472,
      "summary": {
        "text": "Case 2 describes an institute running three donor-funded prevention projects in developing countries, covering HIV testing and counselling for adolescents, prenatal care with HIV partner notification, and a condom programme that sanctions brothel owners, each with a required evaluation. The institute argues that these low-risk operations evaluations need no ethics review, and the questions ask what separates research from programme evaluation, whether oversight is needed and how risk bears on review.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "youth says",
          "heading": false
        },
        {
          "term": "ongoing evaluations",
          "heading": false
        },
        {
          "term": "johns hopkins",
          "heading": false
        },
        {
          "term": "south-east asia",
          "heading": false
        },
        {
          "term": "sexual",
          "heading": true
        },
        {
          "term": "institute",
          "heading": false
        },
        {
          "term": "evaluation component",
          "heading": false
        },
        {
          "term": "programmes",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH The Institute for Family and Youth has a contract with a bilateral funding agency to implement family planning and sexually transmitted infections (STI) and HIV preven- tion programmes in developing countries. The funding is conditional on inclusion of an evaluation component. Through its “Healthy Ideas!” programme, the Institute has recently established",
      "extractCut": true
    },
    {
      "id": "sec-009-case-3-a-treatment-for-central-nervous-system-co",
      "number": null,
      "title": "Case 3. A treatment for central nervous system conditions",
      "level": 2,
      "pageStart": 46,
      "pageEnd": 47,
      "labelStart": "44",
      "labelEnd": "45",
      "words": 717,
      "summary": {
        "text": "Case 3 describes a neurosurgeon in an Asian city who has treated over 500 patients with ALS, Parkinson's disease, stroke and paralysis by injecting olfactory cells from aborted fetuses, calling it innovative therapy. He reports stabilization and better quality of life based on videos and a patient survey but refuses placebo-controlled or sham-surgery trials, saying they would harm suffering patients. The questions ask whether this is therapy, experiment or research, whether a placebo trial would be unethical, how effectiveness could otherwise be shown and who should monitor physicians.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "aborted fetuses",
          "heading": false
        },
        {
          "term": "central nervous",
          "heading": true
        },
        {
          "term": "nervous system",
          "heading": true
        },
        {
          "term": "stem cells",
          "heading": false
        },
        {
          "term": "hole",
          "heading": false
        },
        {
          "term": "spinal",
          "heading": false
        },
        {
          "term": "north american",
          "heading": false
        },
        {
          "term": "surgery",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Dr W is a neurosurgeon in a hospital in one of Asia’s major metropolitan centres. He earned his medical degree in that city and then studied in the United States of America before returning to practise in his own country. Over the past 3 years, Dr W has treated more than 500 patients with central nervous system (CNS) conditions – including amyotrophic",
      "extractCut": true
    },
    {
      "id": "sec-010-case-4-documenting-the-health-conditions-of-an-i",
      "number": null,
      "title": "Case 4. Documenting the health conditions of an indigenous community",
      "level": 2,
      "pageStart": 47,
      "pageEnd": 49,
      "labelStart": "45",
      "labelEnd": "47",
      "words": 590,
      "summary": {
        "text": "Case 4 describes a university team asked, under a tight three-month funding deadline, to document the health of an isolated indigenous community in South America, which begins survey work and a photographic database while its blood sampling and genetic analysis await ethics committee approval. After a child develops meningitis and the community blames the researchers' photographs, the questions ask whether demographic data collection required approval, what safeguards isolated groups need, and what the investigators owe to children who fall ill during the study.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "indigenous community",
          "heading": true
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "genetic characterization",
          "heading": false
        },
        {
          "term": "ethics approval",
          "heading": false
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "blood sampling",
          "heading": false
        },
        {
          "term": "blood collection",
          "heading": false
        },
        {
          "term": "research team",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH The farmers and forest workers of a largely rural district of South America have recently renewed contacts with an isolated indigenous community in order to gain access to their natural resources. The public health agency fears that this interaction will cause higher incidences of infectious diseases and possibly mortality in the indigenous people. The",
      "extractCut": true
    },
    {
      "id": "sec-011-chapter-ii-issues-in-study-design",
      "number": null,
      "title": "Chapter II Issues in Study Design",
      "level": 1,
      "pageStart": 49,
      "pageEnd": 57,
      "labelStart": "47",
      "labelEnd": "55",
      "words": 4258,
      "summary": {
        "text": "Introduces Chapter II on study design, starting with whether research ethics committees should judge the scientific quality of the protocols they review. It argues that a study too flawed to yield knowledge cannot justify burdens on participants, yet sound design alone does not make research ethical, and a less burdensome design may have to be weighed against lower scientific value. It considers who should carry out scientific review, favouring separate review where resources allow and suitable expertise on committees where they do not, before turning to specific design questions such as placebo controls. The chapter introduction ends with annotated suggested readings on topics including clinical equipoise and the use of mystery clients.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "design issues",
          "heading": true
        },
        {
          "term": "study design",
          "heading": true
        },
        {
          "term": "genuine equipoise",
          "heading": false
        },
        {
          "term": "ethical research",
          "heading": false
        },
        {
          "term": "placebo designs",
          "heading": false
        },
        {
          "term": "scientific design",
          "heading": false
        },
        {
          "term": "international ethical",
          "heading": false
        },
        {
          "term": "clinical equipoise",
          "heading": false
        }
      ],
      "extract": "Issues in Study Design © WHO/Christopher Black 48 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH One of the most contentious issues in research ethics is whether or not research ethics committees (RECs) should assess the scientific adequacy of the research protocols they review. RECs typically have this responsibility (although there may also be a scientific review committee constituted to do this) but",
      "extractCut": true
    },
    {
      "id": "sec-012-case-5-referral-of-severely-ill-children-to-hosp",
      "number": null,
      "title": "Case 5. Referral of severely ill children to hospital",
      "level": 2,
      "pageStart": 57,
      "pageEnd": 58,
      "labelStart": "55",
      "labelEnd": "56",
      "words": 595,
      "summary": {
        "text": "Case 5 describes a prospective study in South-East Asia tracking how many severely ill children under five referred to hospital under IMCI guidelines actually reach care, with caregiver interviews at the first-level facility and follow-up home visits, offering help to reach hospital for those who have not. It asks whether the study poses an ethical dilemma and whether researchers' presence obliges them to offer assistance, including monetary help that would not last beyond the study.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ill children",
          "heading": true
        },
        {
          "term": "children caregivers",
          "heading": false
        },
        {
          "term": "first-level facility",
          "heading": false
        },
        {
          "term": "hospital",
          "heading": true
        },
        {
          "term": "first-level facilities",
          "heading": false
        },
        {
          "term": "referral",
          "heading": true
        },
        {
          "term": "children judged",
          "heading": false
        },
        {
          "term": "accessed hospital",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Globally, nearly 10 million children younger than 5 years die each year with the vast majority of these deaths occurring in developing countries. Seventy percent are due to acute respiratory infections, diarrhoeal diseases, malaria, measles, malnutrition, or some combination of these. The Integrated Management of Childhood Illness (IMCI) strategy was",
      "extractCut": true
    },
    {
      "id": "sec-013-case-6-negotiating-safe-sex-practices",
      "number": null,
      "title": "Case 6. Negotiating safe sex practices",
      "level": 2,
      "pageStart": 58,
      "pageEnd": 59,
      "labelStart": "56",
      "labelEnd": "57",
      "words": 549,
      "summary": {
        "text": "Case 6 describes an anthropologist's study in a west African country in which research associates posed as male clients to learn how women in the sex trade negotiate condom use, approved by the health ministry's ethics committee on condition that the women were paid for lost time. An international journal later judged the deception unethical, and the case asks whether the design was justified, what the committee could have advised, whether the journal should defer to the local approval, and how results could be shared with participants.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "fake customers",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "sex",
          "heading": true
        },
        {
          "term": "research design",
          "heading": false
        },
        {
          "term": "sex trade",
          "heading": false
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "ethical code",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Dr J, a European anthropologist who has extensive experience in a west African country, designed a study in that country to examine whether and how women involved in the sex trade negotiate condom use by their male partners. Information about this behaviour might help to reduce the incidence of HIV/AIDS in this population. The study investigated the sex",
      "extractCut": true
    },
    {
      "id": "sec-014-case-7-investigating-treatment-recommendations",
      "number": null,
      "title": "Case 7. Investigating treatment recommendations",
      "level": 2,
      "pageStart": 59,
      "pageEnd": 60,
      "labelStart": "57",
      "labelEnd": "58",
      "words": 388,
      "summary": {
        "text": "Case 7 describes a planned study at a south Asian infectious-disease hospital in which young men posing as villagers would ask drug sellers for advice on treating a child's diarrhoea and buy what was recommended, without the sellers knowing or consenting. It asks whether sellers have a right to know they are studied, whether the investigator should intervene with those giving risky advice, how risks and community benefits compare, and whether all sellers should be debriefed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "drug sellers",
          "heading": false
        },
        {
          "term": "place customers",
          "heading": false
        },
        {
          "term": "investigator",
          "heading": false
        },
        {
          "term": "research study",
          "heading": false
        },
        {
          "term": "recommendations place",
          "heading": false
        },
        {
          "term": "investigating",
          "heading": true
        },
        {
          "term": "intervene",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH An investigator at an infectious-disease hospital in a south Asian country wants to know what remedies drug sellers and pharmacists are recommending for the treatment of diar- rhoea, in order to develop educational materials for both the drug sellers and patients. The investigator believes that drug sellers would not answer him truthfully if he identifies",
      "extractCut": true
    },
    {
      "id": "sec-015-case-8-testing-a-new-hbv-vaccine",
      "number": null,
      "title": "Case 8. Testing a new HBV vaccine",
      "level": 2,
      "pageStart": 60,
      "pageEnd": 61,
      "labelStart": "58",
      "labelEnd": "59",
      "words": 619,
      "summary": {
        "text": "Case 8 sets out the burden of chronic hepatitis B in developing countries and the shift from plasma-derived to recombinant vaccines because of safety concerns. It describes a randomized, double-blind trial in a large Asian country of a North American company's new recombinant vaccine, comparing it with plasma-derived vaccine and placebo in 240 infants of HBsAg-positive mothers, at a time when local vaccine coverage was below 20%. The questions ask whether a placebo arm was ethical, how the study could be improved, and whether consent from one parent was enough.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hbv vaccine",
          "heading": true
        },
        {
          "term": "recombinant vaccine",
          "heading": false
        },
        {
          "term": "hepatitis vaccine",
          "heading": false
        },
        {
          "term": "hbv infection",
          "heading": false
        },
        {
          "term": "experimental group",
          "heading": false
        },
        {
          "term": "hbsag",
          "heading": false
        },
        {
          "term": "clinical trial",
          "heading": false
        },
        {
          "term": "control group",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Of the five hepatitis viruses, hepatitis B (HBV) is the most seri- ous since it can cause lifelong infections that place victims at high risk of death from cirrhosis of the liver and liver cancer – diseases that kill about a million people every year. Chronic HBV infections are most common in developing countries where most people who have the virus are",
      "extractCut": true
    },
    {
      "id": "sec-016-case-9-tuberculosis-prevention-in-hiv-positive-p",
      "number": null,
      "title": "Case 9. Tuberculosis prevention in HIV-positive people",
      "level": 2,
      "pageStart": 61,
      "pageEnd": 62,
      "labelStart": "59",
      "labelEnd": "60",
      "words": 676,
      "summary": {
        "text": "Case 9 explains that tuberculosis is a leading cause of death among people with HIV and that isoniazid was the standard preventive therapy for high-risk HIV-negative people, recommended in the United States for HIV-infected people but not then policy in developing countries. It describes a 1993–1995 randomized, placebo-controlled trial among 3000 HIV-positive African adults comparing placebo, six months of isoniazid and two shorter, costlier multi-drug regimens, with the placebo justified by doubts about safety and efficacy in HIV infection. The questions ask whether the placebo was justified, how it differs from no treatment, and whether testing an unaffordable regimen in Africa was appropriate.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv-positive",
          "heading": true
        },
        {
          "term": "inh",
          "heading": false
        },
        {
          "term": "preventive therapy",
          "heading": false
        },
        {
          "term": "johns hopkins",
          "heading": false
        },
        {
          "term": "placebo",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        },
        {
          "term": "people",
          "heading": true
        },
        {
          "term": "rifampin",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Although this case is based on research that happened more than a decade ago, it is included here because similar ethical questions arise in contemporary clinical trials. Pulmonary Tuberculosis (TB) is a highly contagious lung disease which, like the common cold, is spread by the transfer of germs from an infected person to a non-infected person. Many",
      "extractCut": true
    },
    {
      "id": "sec-017-case-10-developing-a-vaccine-for-malaria",
      "number": null,
      "title": "Case 10. Developing a vaccine for malaria",
      "level": 2,
      "pageStart": 62,
      "pageEnd": 64,
      "labelStart": "60",
      "labelEnd": "62",
      "words": 1211,
      "summary": {
        "text": "Case 10 describes the burden of malaria, concentrated in tropical Africa and among children, and a planned efficacy trial of a North American university's multi-stage DNA vaccine in children under five in a sub-Saharan district with strong community surveillance but very few health services. Children would be randomly chosen from the surveillance database and given vaccine or placebo double-blind, with death as the endpoint, so investigators could not treat malaria cases even though nearly all deaths could cheaply be prevented. The questions cover whether a placebo is appropriate, whether to provide treatment, other duties of care, whether death is the right measure, how ethics should shape the design, and who must ensure local ethics review.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "malaria",
          "heading": true
        },
        {
          "term": "vaccine",
          "heading": true
        },
        {
          "term": "vaccine efficacy",
          "heading": false
        },
        {
          "term": "effective vaccine",
          "heading": false
        },
        {
          "term": "deaths due",
          "heading": false
        },
        {
          "term": "north american",
          "heading": false
        },
        {
          "term": "ethical obligation",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH In the past decade, the rapid rise in the incidence of malaria has been so alarming that it is considered a re-emerging disease. In 2006 alone, an estimated 250-300 million cases resulted in almost a million deaths worldwide. Many of those who die are children: malaria kills one child every 30 seconds. Countries in tropical Africa account for more than 90%",
      "extractCut": true
    },
    {
      "id": "sec-018-case-11-should-race-be-listed-as-a-risk-factor",
      "number": null,
      "title": "Case 11. Should race be listed as a risk factor?",
      "level": 2,
      "pageStart": 64,
      "pageEnd": 65,
      "labelStart": "62",
      "labelEnd": "63",
      "words": 562,
      "summary": {
        "text": "Case 11 describes a southern African STI clinic director who, seeing twice as many STI cases among people self-identified as coloured as among those identified as black, plans a survey including race and ethnicity as risk factors on the hypothesis of biological susceptibility. A community member of the ethics committee objects that the findings would reinforce stigma and questions the biological basis, and the case asks whose view is right, whether politically constructed racial categories belong in science, and how the protocol could be strengthened.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "coloured people",
          "heading": false
        },
        {
          "term": "race",
          "heading": true
        },
        {
          "term": "coloured population",
          "heading": false
        },
        {
          "term": "racial categories",
          "heading": false
        },
        {
          "term": "common descent",
          "heading": false
        },
        {
          "term": "chingana",
          "heading": false
        },
        {
          "term": "factor",
          "heading": true
        },
        {
          "term": "she",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Records from the sexually transmitted infection (STI) clinic at the largest general hospital in a southern African country indicate that the segment of the population self-ascribed as “coloured” has twice as many cases of STIs as the segment that is self-ascribed as “black”. By contrast, for almost all other conditions seen in the hospital’s outpatient",
      "extractCut": true
    },
    {
      "id": "sec-019-case-12-short-course-azt-to-prevent-mother-to-ch",
      "number": null,
      "title": "Case 12. Short-course AZT to prevent mother-to-child transmission of HIV",
      "level": 2,
      "pageStart": 65,
      "pageEnd": 67,
      "labelStart": "63",
      "labelEnd": "65",
      "words": 957,
      "summary": {
        "text": "Case 12 recounts the placebo-controlled trials of short-course zidovudine (AZT) to prevent mother-to-child HIV transmission in sub-Saharan Africa and the Asia-Pacific, proposed because the long-course 076 regimen was seen as impractical and unaffordable there. Researchers defended the placebo as matching the local reality of no treatment and allowing faster adoption, while critics, mainly in the West, argued it breached the Declaration of Helsinki, whose placebo provisions are quoted in a footnote, and reflected a double standard. The questions ask whether donor-institution committees should insist on long-course controls, whether a likely less effective regimen should be tested, and whether a trial impossible in rich countries implies a double standard.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "short-course azt",
          "heading": true
        },
        {
          "term": "long-course regimen",
          "heading": false
        },
        {
          "term": "long-course treatment",
          "heading": false
        },
        {
          "term": "placebo controls",
          "heading": false
        },
        {
          "term": "course regimen",
          "heading": false
        },
        {
          "term": "short course",
          "heading": false
        },
        {
          "term": "long course",
          "heading": false
        },
        {
          "term": "researchers proposed",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH The risk of vertical transmission of HIV during pregnancy and delivery has been estimated at 15-30%, depending on several factors, including the stage of the mother’s illness and whether it has been treated. In the mid-1990s, the best- known method for prevention of maternal HIV transmission was the “076 regimen”, or long-course AZT treatment, in which a",
      "extractCut": true
    },
    {
      "id": "sec-020-case-13-testing-an-ayurvedic-medicine-for-malari",
      "number": null,
      "title": "Case 13. Testing an ayurvedic medicine for malaria",
      "level": 2,
      "pageStart": 67,
      "pageEnd": 69,
      "labelStart": "65",
      "labelEnd": "67",
      "words": 956,
      "summary": {
        "text": "Case 13 describes the retesting of Ayush-64, a patented combination of four Ayurvedic drugs used for decades against malaria in South Asia but never studied for toxicity and supported only by an older study without laboratory confirmation. In a randomized trial approved by the malaria research centre's ethics committee, adults with confirmed P. vivax malaria at periurban clinics received either the national chloroquine–primaquine regimen or Ayush-64, with non-responders switched to standard treatment and no follow-up of drop-outs; footnotes explain chloroquine, the malaria species, Ayurveda and primaquine. The questions ask what evidence is needed before human testing, whether traditional therapies should be treated differently, whether the study was ethical, and what was owed to drop-outs.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vivax malaria",
          "heading": false
        },
        {
          "term": "plasmodium vivax",
          "heading": false
        },
        {
          "term": "plasmodium falciparum",
          "heading": false
        },
        {
          "term": "malaria research",
          "heading": false
        },
        {
          "term": "ayurvedic",
          "heading": true
        },
        {
          "term": "ayush",
          "heading": false
        },
        {
          "term": "ayurveda",
          "heading": false
        },
        {
          "term": "research centre",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Malaria is a major health problem in many areas of South Asia. Due largely to problems of drug resistance and treatment failure of chloroquine,1 a common therapy for Plasmodium falciparum and Plasmodium vivax malaria,2 there is great interest in exploring new drugs, drug combinations, and/or indigenous remedies to combat these malarial agents. Ayush-64 is a",
      "extractCut": true
    },
    {
      "id": "sec-021-case-14-evaluating-the-use-of-traditional-medici",
      "number": null,
      "title": "Case 14. Evaluating the use of traditional medicines for diarrhoea",
      "level": 2,
      "pageStart": 69,
      "pageEnd": 70,
      "labelStart": "67",
      "labelEnd": "68",
      "words": 601,
      "summary": {
        "text": "Case 14 concerns 'ajorno', a cheap and popular South Asian traditional medicine based on the plant thankuni, reputed to treat bloody diarrhoea but never clinically studied and of unknown chemical composition. An investigator proposes a double-blind trial against norfloxacin, the effective but often unavailable and costly antibiotic for dysentery, but the ethics committee rejects it, citing unknown composition, vague prior reports and no peer-reviewed evidence. He accuses the committee of Western bias, and the questions ask whether the committee was right, whether the bias charge holds, whether approval would imply a double standard, and how such disagreements could be mediated.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "traditional medicines",
          "heading": true
        },
        {
          "term": "diarrhoea",
          "heading": true
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "chemical composition",
          "heading": false
        },
        {
          "term": "thankuni",
          "heading": false
        },
        {
          "term": "ajorno",
          "heading": false
        },
        {
          "term": "voted against",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Hydrocotyle asiatica, or ‘thankuni’, is a plant common to South Asia which, when dried, ground up, and added to water, is reported to be effective for treatment of bloody diarrhoea. ‘Thankuni’ is the main ingredient of a popular traditional medicine, ‘ajorno’, which is produced by a local company. This medicine is widely available, very popular, and quite",
      "extractCut": true
    },
    {
      "id": "sec-022-case-15-twin-registry-genetics",
      "number": null,
      "title": "Case 15. Twin registry genetics",
      "level": 2,
      "pageStart": 70,
      "pageEnd": 71,
      "labelStart": "68",
      "labelEnd": "69",
      "words": 525,
      "summary": {
        "text": "Case 15 describes a European and South-East Asian population twin study of about 2000 twin pairs and 1000 singletons, examining genetic versus environmental causes and prevalence of common mental disorders, using interviews and cheek swabs to determine twin type, and excluding the illiterate and severely mentally ill. Participants needing treatment would be referred without follow-up, and relatives contacted for those at serious suicide risk, and the questions ask whether the exclusions are acceptable, whether referral alone meets researchers' obligations, and what is owed to twins of severely ill individuals.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "twin",
          "heading": true
        },
        {
          "term": "mental disorders",
          "heading": false
        },
        {
          "term": "somatoform disorders",
          "heading": false
        },
        {
          "term": "mental illnesses",
          "heading": false
        },
        {
          "term": "suicidal ideation",
          "heading": false
        },
        {
          "term": "severe mental",
          "heading": false
        },
        {
          "term": "common mental",
          "heading": false
        },
        {
          "term": "alcohol dependency",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH The extent to which common mental disorders, including alcohol dependency and suicidal ideation, are caused by genetic factors versus environmental ones remains unclear. Promising twin-study research on mental disorders has been conducted in developed countries, but such studies might not be relevant for developing countries. Collaborating investigators",
      "extractCut": true
    },
    {
      "id": "sec-023-case-16-observing-newborn-care-practices",
      "number": null,
      "title": "Case 16. Observing newborn care practices",
      "level": 2,
      "pageStart": 71,
      "pageEnd": 72,
      "labelStart": "69",
      "labelEnd": "70",
      "words": 417,
      "summary": {
        "text": "Case 16 of the WHO casebook on ethics in international health research describes an observational study of newborn care in an East Asian community with high neonatal mortality, in which field workers are told only to record practices, and one watches a mother prepare formula with unboiled river water, diluted too much. Questions ask whether the worker should intervene and when, whether the study could have been designed to avoid the dilemma, what investigators owe participants in observational studies, and whether visitors to the household need to give consent.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "newborn care",
          "heading": true
        },
        {
          "term": "care practices",
          "heading": true
        },
        {
          "term": "observing",
          "heading": true
        },
        {
          "term": "field worker",
          "heading": false
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "warmth",
          "heading": false
        },
        {
          "term": "baby",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Each year, about four million infants in developing countries die during their first month of life. Many of these deaths could be prevented by improving newborn care practices such as proper breastfeeding, hygiene, warmth, and quick access to health care. A group of university researchers in an East Asian country are conducting an observational study that",
      "extractCut": true
    },
    {
      "id": "sec-024-case-17-compassionate-intervention-during-an-obs",
      "number": null,
      "title": "Case 17. Compassionate intervention during an observational study",
      "level": 2,
      "pageStart": 72,
      "pageEnd": 73,
      "labelStart": "70",
      "labelEnd": "71",
      "words": 493,
      "summary": {
        "text": "Case 17 concerns a field worker in an observational newborn-care study in East Asia, instructed not to intervene, who is asked by a family to help an older child with a high fever who cannot easily be taken to a distant, poorly staffed health facility. The questions explore whether care outside a study's design can be ethically required, how observational researchers should respond to inadequate local health services, and how the field worker might balance compassion against the risk of many further requests.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "observational study",
          "heading": true
        },
        {
          "term": "field worker",
          "heading": false
        },
        {
          "term": "compassionate",
          "heading": true
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "study design",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        },
        {
          "term": "health care",
          "heading": false
        },
        {
          "term": "sibling",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH A field worker is conducting observations in households with infants younger than 3 months in an East Asian community with high infant mortality. This is being done as part of an observational study to gather data to generate evidence to promote more appropriate newborn care. The study has been approved by an appropriate research ethics committee. The field",
      "extractCut": true
    },
    {
      "id": "sec-025-chapter-iii-harm-and-benefit",
      "number": null,
      "title": "Chapter III Harm and Benefit",
      "level": 1,
      "pageStart": 73,
      "pageEnd": 78,
      "labelStart": "71",
      "labelEnd": "76",
      "words": 1998,
      "summary": {
        "text": "Introduces Chapter III on harm and benefit, asking whether the risks and gains of research are fairly shared and how participants should be chosen when a study offers advantages. It discusses the difficult task research ethics committees face in weighing burdens on participants against benefits to others, especially in early-phase drug trials, and the role of independent data and safety monitoring boards in halting trials early. The section ends with suggested readings, including works on research with children, the export of tissue samples and research in poor countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "harm",
          "heading": true
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "microbicide research",
          "heading": false
        },
        {
          "term": "ethical concerns",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "potential harms",
          "heading": false
        },
        {
          "term": "studies harm",
          "heading": false
        },
        {
          "term": "research study",
          "heading": false
        }
      ],
      "extract": "Harm and Benefit © WHO 72 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Research with human participants raises ethical concerns precisely because the research that scientists might need to do in order to obtain useful knowledge might not always serve participants’ best interests. When scientific needs coincide with participants’ interests, studies are usually unproblematic. In this ideal scenario,",
      "extractCut": true
    },
    {
      "id": "sec-026-case-18-rotavirus-vaccine",
      "number": null,
      "title": "Case 18. Rotavirus vaccine",
      "level": 2,
      "pageStart": 78,
      "pageEnd": 80,
      "labelStart": "76",
      "labelEnd": "78",
      "words": 1125,
      "summary": {
        "text": "Case 18 sets out the burden of rotavirus, which causes an estimated 527 000 deaths a year mostly among young children in low-income countries, and recounts how a rhesus rotavirus vaccine licensed in North America was withdrawn after reports linking it to intussusception. A developing country's ministry of health, weighing a 1 in 100 risk of rotavirus death against a 1 in 10 000 vaccine risk, asks a state-run company to produce the vaccine locally, but the manufacturer refuses to transfer the technology, leaving compulsory licensing under the TRIPS Agreement as a possible route. Questions ask whether the vaccine should be used where rotavirus kills many children, what level of risk is acceptable and who decides, and whether the manufacturer or the country has obligations regarding patent rights.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "rotavirus vaccine",
          "heading": true
        },
        {
          "term": "ldc pharma",
          "heading": false
        },
        {
          "term": "north american",
          "heading": false
        },
        {
          "term": "american company",
          "heading": false
        },
        {
          "term": "patent rights",
          "heading": false
        },
        {
          "term": "american manufacturer",
          "heading": false
        },
        {
          "term": "rrv-tv",
          "heading": false
        },
        {
          "term": "ethical difference",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Rotavirus is one of the most common causes of severe diar- rhoeal disease and dehydration in infants and young children in both developed and developing countries. The virus, which infects almost all children by the time they are aged 2 or 3 years, appears to be as prevalent in high-income as in low- income countries despite wide differences in the",
      "extractCut": true
    },
    {
      "id": "sec-027-case-19-pneumonia-vaccine-trial",
      "number": null,
      "title": "Case 19. Pneumonia vaccine trial",
      "level": 2,
      "pageStart": 80,
      "pageEnd": 81,
      "labelStart": "78",
      "labelEnd": "79",
      "words": 465,
      "summary": {
        "text": "Case 19 describes an African trial of a European pneumococcal vaccine in 20 000 infants, which protected 90% of vaccinated children up to age 3, after which some scientists wanted to leave controls unvaccinated to study protection in older children and long-term safety, though all controls were vaccinated. Questions ask whether those scientists were right, whether parental consent could justify withholding the vaccine, and whether further tests in older children would be justified.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccine trial",
          "heading": true
        },
        {
          "term": "placebo-controlled trial",
          "heading": false
        },
        {
          "term": "children older",
          "heading": false
        },
        {
          "term": "pneumococcal disease",
          "heading": false
        },
        {
          "term": "controls",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "long-term safety",
          "heading": false
        },
        {
          "term": "unique opportunity",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH A childhood vaccine for pneumococcal disease, one of the most important causes of child deaths in the developing world, has been developed by a European pharmaceutical company and tested at a site in Africa. The goal of the trial was to determine how many children would be protected from the disease before the age of 3 years. In this community, and in the",
      "extractCut": true
    },
    {
      "id": "sec-028-case-20-early-termination-of-a-trial",
      "number": null,
      "title": "Case 20. Early termination of a trial",
      "level": 2,
      "pageStart": 81,
      "pageEnd": 82,
      "labelStart": "79",
      "labelEnd": "80",
      "words": 551,
      "summary": {
        "text": "Case 20 describes a breast cancer recurrence-prevention trial in which the data safety monitoring board, seeing a strong but not statistically significant trend favouring the drug after three years, recommended stopping and offering it to all, which a leading patient organization criticised for leaving the drug's benefit uncertain. Questions ask whether the board should have acted on a trend, whether the ethics committee should have been involved, what role such boards should have, and when moral choices may override statistical significance.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "breast cancer",
          "heading": false
        },
        {
          "term": "trial",
          "heading": true
        },
        {
          "term": "termination",
          "heading": true
        },
        {
          "term": "moral choices",
          "heading": false
        },
        {
          "term": "investigators",
          "heading": false
        },
        {
          "term": "statistical significance",
          "heading": false
        },
        {
          "term": "monitoring board",
          "heading": false
        },
        {
          "term": "trend",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH From a global perspective, breast cancer is the most common cause of cancer deaths in women. Although breast cancer is increasingly being discovered early enough for surgery to be a beneficial intervention, many surviving women live in fear of recurrence. The search for interventions to prevent this even- tuality has for many years been a high priority for",
      "extractCut": true
    },
    {
      "id": "sec-029-case-21-pregnancy-in-health-research",
      "number": null,
      "title": "Case 21. Pregnancy in health research",
      "level": 2,
      "pageStart": 82,
      "pageEnd": 83,
      "labelStart": "80",
      "labelEnd": "81",
      "words": 789,
      "summary": {
        "text": "Case 21 describes a North American NGO's trial of a vaginal microbicide to prevent HIV in high-risk women, often sex workers, in four African countries and one South Asian country, which excluded pregnant women and required monthly pregnancy tests. Many participants paused for pregnancy and returned within three months, suggesting abortions, in countries where safe legal abortion is limited or unavailable to varying degrees. Questions ask what researchers and sponsors should now do, including whether to provide safe abortion or warn of the risk, and whether such studies should be done where safe abortion is not available; in the extracted text the closing part of the case appears before its opening.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaginal microbicides",
          "heading": false
        },
        {
          "term": "safe abortions",
          "heading": false
        },
        {
          "term": "health research",
          "heading": true
        },
        {
          "term": "pregnancy",
          "heading": true
        },
        {
          "term": "until she",
          "heading": false
        },
        {
          "term": "become pregnant",
          "heading": false
        },
        {
          "term": "study participation",
          "heading": false
        },
        {
          "term": "longer pregnant",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH such procedures is usually quite high. In countries D and E, legal abortion is available only to save the life of the woman; however, both safe and unsafe services exist at a price. Questions 1 What should the researchers do now that they know many participants are becoming pregnant while participating in the study and that many are probably having illegal",
      "extractCut": true
    },
    {
      "id": "sec-030-case-22-acting-in-the-face-of-conflicting-eviden",
      "number": null,
      "title": "Case 22. Acting in the face of conflicting evidence",
      "level": 2,
      "pageStart": 83,
      "pageEnd": 85,
      "labelStart": "81",
      "labelEnd": "83",
      "words": 771,
      "summary": {
        "text": "Case 22 recounts the controversy over non-surgical sterilization using intrauterine quinacrine, given to about 104 500 women before reports of a cancer cluster and laboratory evidence of cell mutation led to suspension of the main programme. A small group of North American population-research scientists kept promoting the drug, pointing to its effectiveness, safety and maternal deaths avoided, and organized its distribution without further studies or approval for this purpose. The questions ask whether such use can be justified where maternal mortality is high, whether drugs not registered in the exporting country should be exported to developing countries, and whether the scientists' conduct was a form of misconduct.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "quinacrine sterilization",
          "heading": false
        },
        {
          "term": "surgical sterilization",
          "heading": false
        },
        {
          "term": "steri lization",
          "heading": false
        },
        {
          "term": "exporting country",
          "heading": false
        },
        {
          "term": "south american",
          "heading": false
        },
        {
          "term": "studies harm",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        },
        {
          "term": "ethical issues",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH Although this case is based on research and a situation that happened in the mid-1990s, it is included here because the ethical questions remain relevant. See Case 34 for more details on the quinacrine trials. Effective and accessible methods of avoiding pregnancy are important not only for control of family size but also for reduction of maternal",
      "extractCut": true
    },
    {
      "id": "sec-031-chapter-iv-voluntary-informed-consent",
      "number": null,
      "title": "Chapter IV Voluntary Informed Consent",
      "level": 1,
      "pageStart": 85,
      "pageEnd": 94,
      "labelStart": "83",
      "labelEnd": "92",
      "words": 4870,
      "summary": {
        "text": "Introduces Chapter IV on voluntary informed consent, tracing its origins to the Nuremberg Code and its later development in the Declaration of Helsinki and the CIOMS guidelines. It sets out the three core elements of valid consent: capacity to decide, voluntariness and enough understandable information. The text discusses how unfamiliar research concepts can limit adults' understanding, how offers of money or free care can undermine free choice for people with no other access to them, and how some minors are able to make competent decisions. It ends with annotated readings on community engagement and consent in settings such as a vaccine trial in rural Senegal and the International HapMap Project.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "informed consent",
          "heading": true
        },
        {
          "term": "voluntary informed",
          "heading": true
        },
        {
          "term": "obtaining consent",
          "heading": false
        },
        {
          "term": "nuremberg code",
          "heading": false
        },
        {
          "term": "written consent",
          "heading": false
        },
        {
          "term": "nuremberg tribunal",
          "heading": false
        },
        {
          "term": "individual consent",
          "heading": false
        },
        {
          "term": "consent process",
          "heading": false
        }
      ],
      "extract": "Voluntary Informed Consent © WHO 84 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent Although informed consent had appeared in codes of ethics for scientific research as early as the nineteenth century,1 its central importance was firmly established in the “Doctors’ Trial” before the Nuremberg Tribunal at the end of the Second World War. In passing judgment",
      "extractCut": true
    },
    {
      "id": "sec-032-case-23-testing-high-doses-of-vitamin-a-on-child",
      "number": null,
      "title": "Case 23. Testing high doses of vitamin A on children",
      "level": 2,
      "pageStart": 94,
      "pageEnd": 95,
      "labelStart": "92",
      "labelEnd": "93",
      "words": 488,
      "summary": {
        "text": "Case 23 describes a double-blind trial of periodic high-dose vitamin A against childhood diarrhoea and acute respiratory infections in a rural West African community, where the chief and council approve the study after a public meeting but parents decline to sign consent forms and the chief threatens to expel the field team if it insists. Questions ask whether individual informed consent is a universal principle or culturally bound, whether leaders may consent for the community, when individual consent is unnecessary, and how the team and funder should respond.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "vitamin",
          "heading": true
        },
        {
          "term": "consent forms",
          "heading": false
        },
        {
          "term": "individual informed",
          "heading": false
        },
        {
          "term": "chief",
          "heading": false
        },
        {
          "term": "children",
          "heading": true
        },
        {
          "term": "field team",
          "heading": false
        },
        {
          "term": "field staff",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent The ministry of health of a West African country receives a grant from a foreign medical institute to collaborate with its investigators on a double-blind study designed to assess the effect of periodic high doses of vitamin A on the incidences of childhood diarrhoea and acute respiratory infections (ARI).",
      "extractCut": true
    },
    {
      "id": "sec-033-case-24-breast-cancer-in-south-asia",
      "number": null,
      "title": "Case 24. Breast cancer in South Asia",
      "level": 2,
      "pageStart": 95,
      "pageEnd": 97,
      "labelStart": "93",
      "labelEnd": "95",
      "words": 917,
      "summary": {
        "text": "Case 24 describes a proposed trial by North American researchers in a South Asian country comparing ovary removal plus tamoxifen with no adjuvant treatment in 350 premenopausal women after breast cancer surgery, which the researchers say could not be run with a placebo arm in the United States. The principal investigator plans to leave out alternative therapies and randomization from the consent process, arguing that paternalistic medical culture there makes expressing uncertainty unacceptable, and supports this with views from South Asian immigrants, women's union officials and local physicians. Questions ask whether cultural differences justify a different consent approach, whether the outside views strengthen the case, and whether running such a study in a poor country because rich countries would not accept it is justified.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "breast cancer",
          "heading": true
        },
        {
          "term": "adjuvant therapy",
          "heading": false
        },
        {
          "term": "surgical removal",
          "heading": false
        },
        {
          "term": "premenopausal women",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "tamoxifen",
          "heading": false
        },
        {
          "term": "researchers contend",
          "heading": false
        },
        {
          "term": "asian country",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Voluntary Informed Consent ❚ This case is based on research that was conducted at a time when the role of tamoxifen for management of breast cancer was not well defined. Currently, it is an accepted form of adjuvant therapy in these patients. Researchers from a North American university propose to study a new adjuvant therapy1 called",
      "extractCut": true
    },
    {
      "id": "sec-034-case-25-testing-a-microbicide",
      "number": null,
      "title": "Case 25. Testing a microbicide",
      "level": 2,
      "pageStart": 97,
      "pageEnd": 99,
      "labelStart": "95",
      "labelEnd": "97",
      "words": 1178,
      "summary": {
        "text": "Case 25 of this casebook on ethical issues in international health research, filed under voluntary informed consent, describes a planned phase II trial by a North American feminist non-profit organization of a non-contraceptive vaginal microbicide gel among 300 HIV-negative women at family planning clinics in an African country. Participants were to use the gel or a placebo for about a year, with monthly check-ups, treatment of STIs, HIV testing every three months with counselling and the option not to receive results, referral if infected, and modest compensation. The researchers chose not to seek consent from the women's partners, which a community health committee opposed as exposing women to abuse, and the questions cover partner consent and notification, how the committee can be heard, and withholding HIV test results.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "microbicide",
          "heading": true
        },
        {
          "term": "vaginal microbicide",
          "heading": false
        },
        {
          "term": "pwi researchers",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "trichomonas vaginalis",
          "heading": false
        },
        {
          "term": "voluntary informed",
          "heading": false
        },
        {
          "term": "seek informed",
          "heading": false
        },
        {
          "term": "transmitted infections",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Voluntary Informed Consent ❚ Expansion of the range of woman-controlled methods to prevent all sexually transmitted infections (STIs) is critical to stemming the spread of the HIV/AIDS pandemic. A vaginal microbicide1 could offer women the potential to protect themselves from HIV and other STIs. The ideal microbicide would be effective,",
      "extractCut": true
    },
    {
      "id": "sec-035-case-26-a-study-to-determine-the-value-of-postop",
      "number": null,
      "title": "Case 26. A study to determine the value of postoperative radiotherapy",
      "level": 2,
      "pageStart": 99,
      "pageEnd": 100,
      "labelStart": "97",
      "labelEnd": "98",
      "words": 505,
      "summary": {
        "text": "Case 26 recounts an 11-year randomized study at a cancer hospital in East Asia, run without ethics review, comparing surgery alone with surgery plus radiotherapy for oesophageal cancer, in which patients were offered 'innovative therapy' but not told they were in an experiment because the investigators feared culturally rooted distrust of research. A North American journal published the favourable results together with a critical editorial that the authors were neither shown nor invited to answer, and the questions address the investigators' justification, harm to patients, judging past studies by today's standards and the journal's conduct.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "postoperative radiotherapy",
          "heading": true
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "journal editor",
          "heading": false
        },
        {
          "term": "study",
          "heading": true
        },
        {
          "term": "ethical review",
          "heading": false
        },
        {
          "term": "cancer cells",
          "heading": false
        },
        {
          "term": "oesophageal",
          "heading": false
        },
        {
          "term": "resection",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Voluntary Informed Consent ❚ Over an 11-year period, a well-respected cancer hospital in East Asia studied a much debated issue: whether the survival of patients with oesophageal cancer is improved by radiotherapy after resection (surgical removal of the cancer cells). The study did not receive an ethics review before it was started",
      "extractCut": true
    },
    {
      "id": "sec-036-case-27-micronutrient-supplementation-for-pregna",
      "number": null,
      "title": "Case 27. Micronutrient supplementation for pregnant women",
      "level": 2,
      "pageStart": 100,
      "pageEnd": 102,
      "labelStart": "98",
      "labelEnd": "100",
      "words": 818,
      "summary": {
        "text": "Case 27 describes a community-randomized, placebo-controlled trial in 270 villages of a South Asian country with high poverty and illiteracy, testing whether a weekly low dose of vitamin A or beta-carotene given to married women of reproductive age reduces pregnancy-related death and illness and improves infant growth and survival. Permission came from district health officials, the study was announced by a village crier as a ministry of health initiative, and individual consent was taken only from women who became pregnant, some of whom also had detailed examinations and infant measurements. About three months in, some of the 45 000 enrolled women objected to taking a Western medicine rumoured to be ineffective, and the questions ask about the ethics of randomizing communities, the adequacy of consent and whether participants must understand randomization.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "women",
          "heading": true
        },
        {
          "term": "vitamin deficiency",
          "heading": false
        },
        {
          "term": "village leaders",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "supplementation",
          "heading": true
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "voluntary informed",
          "heading": false
        },
        {
          "term": "beta-carotene",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent Maternal vitamin A deficiency is a major public health problem in South Asia. Premature births and small size for gestational age, both of which are leading risk factors for stillbirths and for neonatal and early childhood death, have been linked to insuf- ficient levels of vitamin A in mothers with low",
      "extractCut": true
    },
    {
      "id": "sec-037-case-28-breastfeeding-and-mother-to-child-hiv-tr",
      "number": null,
      "title": "Case 28. Breastfeeding and mother-to-child HIV transmission",
      "level": 2,
      "pageStart": 102,
      "pageEnd": 104,
      "labelStart": "100",
      "labelEnd": "102",
      "words": 942,
      "summary": {
        "text": "Case 28, based on research from the 1990s, describes a one-year study at a general hospital in a central African country of the risk of HIV transmission through breastfeeding, in which both partners gave consent and HIV-positive women were counselled not to breastfeed and offered free infant formula, so that those who did and did not breastfeed formed non-random comparison groups. Children were tested for HIV up to 18 months and seen every two weeks at a clinic with free medicines. When one HIV-positive woman decided to breastfeed, her husband objected and threatened court action while wanting the family to remain in the study, and the questions cover partner consent, undue inducement, whether the study was needed, its risk-benefit ratio and the investigator's role.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv transmission",
          "heading": true
        },
        {
          "term": "breastfeeding",
          "heading": true
        },
        {
          "term": "infant formula",
          "heading": false
        },
        {
          "term": "infant feeding",
          "heading": false
        },
        {
          "term": "breast milk",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "hiv-infected women",
          "heading": false
        },
        {
          "term": "hiv-positive women",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent This case is based on research that took place in the 1990s and is not based on recent knowledge. It is included here because the ethical questions remain valid.1 A research group based at a medical research institute in a central African country is studying the risk for HIV infec- tion in children who are",
      "extractCut": true
    },
    {
      "id": "sec-038-case-29-humanized-mice",
      "number": null,
      "title": "Case 29. Humanized mice",
      "level": 2,
      "pageStart": 104,
      "pageEnd": 105,
      "labelStart": "102",
      "labelEnd": "103",
      "words": 479,
      "summary": {
        "text": "Case 29 describes a South American university's work towards a dengue vaccine using immunodeficient mice whose immune systems were rebuilt with umbilical-cord blood donated anonymously by about 100 women, whose consent form did not make clear that the blood would be injected into mice. A year later one donor read about 'humanized mice', complained that she felt cheated and demanded that her samples be withdrawn, and the questions ask whether she was properly informed, whether her request was reasonable and what more the women should have been told.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "humanized mice",
          "heading": true
        },
        {
          "term": "dengue haemorrhagic",
          "heading": false
        },
        {
          "term": "haemorrhagic fever",
          "heading": false
        },
        {
          "term": "cord blood",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "consent form",
          "heading": false
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "reconstitute",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent Like malaria, dengue fever is a potentially fatal, mosquito- borne viral disease. Although dengue, with its severe, flu-like symptoms, rarely causes death, dengue haemorrhagic fever, a potentially lethal complication, has become a leading cause of admission to hospital and death among children in several",
      "extractCut": true
    },
    {
      "id": "sec-039-case-30-donations-for-stem-cell-research",
      "number": null,
      "title": "Case 30. Donations for stem-cell research",
      "level": 2,
      "pageStart": 105,
      "pageEnd": 106,
      "labelStart": "103",
      "labelEnd": "104",
      "words": 390,
      "summary": {
        "text": "Case 30 describes how, in a country that allows stem-cell research on embryos up to 14 days old, assisted-reproduction clinics use a single merged form for consent to treatment and to the donation of spare embryos, avoiding words such as donation, research and informed consent because of perceived patient sensitivities. The questions ask whether such terms may be left out, whether one form can cover both purposes, and whether consent can be given for studies not yet defined.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "stem-cell research",
          "heading": true
        },
        {
          "term": "embryos",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "consent form",
          "heading": false
        },
        {
          "term": "assisted reproduction",
          "heading": false
        },
        {
          "term": "donations",
          "heading": true
        },
        {
          "term": "doctor",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Voluntary Informed Consent ❚ In country X, the government allows the use of human embryos up to 14-days-old for stem-cell research. Researchers often acquire embryos through cooperation with clinical insti- tutes that provide assisted-reproduction services. Embryos are usually collected before a specific research study. The doctor",
      "extractCut": true
    },
    {
      "id": "sec-040-case-31-researching-health-care-practices-and-ne",
      "number": null,
      "title": "Case 31. Researching health care practices and needs in an elderly population",
      "level": 2,
      "pageStart": 106,
      "pageEnd": 107,
      "labelStart": "104",
      "labelEnd": "105",
      "words": 519,
      "summary": {
        "text": "Case 31 describes a survey of health practices and needs among elderly members of a formerly nomadic Saharan community, run by a European university with a regional health district, in which researchers asked the household head's permission before interviewing older parents in private. When an 80-year-old man became unwell during a long interview, his son accused the team of making him ill, and the questions consider how this could have been avoided, whether the consent process met older people's needs, and whether ethics committees should have reviewed the survey questions.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "health care",
          "heading": true
        },
        {
          "term": "care practices",
          "heading": true
        },
        {
          "term": "nomadic",
          "heading": false
        },
        {
          "term": "ethics committees",
          "heading": false
        },
        {
          "term": "adult son",
          "heading": false
        },
        {
          "term": "health district",
          "heading": false
        },
        {
          "term": "researching",
          "heading": true
        },
        {
          "term": "researcher",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Voluntary Informed Consent In recent decades, the nomadic populations of the northern Sahara have adopted a more sedentary lifestyle, settling in cities and villages that were once only temporary stopovers. Officials in one regional health district noticed that many elderly members of one of these formerly nomadic communi- ties were",
      "extractCut": true
    },
    {
      "id": "sec-041-chapter-v-standard-of-care",
      "number": null,
      "title": "Chapter V Standard of Care",
      "level": 1,
      "pageStart": 107,
      "pageEnd": 112,
      "labelStart": "105",
      "labelEnd": "110",
      "words": 2542,
      "summary": {
        "text": "Introduces Chapter V on the standard of care owed to control groups in randomized controlled trials, particularly in developing countries. It examines Article 32 of the 2008 Declaration of Helsinki, which requires new methods to be tested against the best proven current method except under specified conditions that permit placebo. The text contrasts a single global standard with readings based on the care available locally, noting that a strict global standard could rule out placebo-controlled trials of affordable alternatives in poor countries. It closes with suggested readings presenting differing views on uniform care requirements, double standards and the dispute over revisions to the Declaration.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "receive placebo",
          "heading": false
        },
        {
          "term": "medical research",
          "heading": false
        },
        {
          "term": "incidental diseases",
          "heading": false
        },
        {
          "term": "standard",
          "heading": true
        },
        {
          "term": "research study",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        }
      ],
      "extract": "Chapter V © WHO/Pierre Virot 106 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Standard of Care Some of the most contentious ethical issues in international health research arise in research studies that use a rand- omized controlled trial (RCT) design to test new methods and treatments. This is especially true in the context of research that is undertaken in developing countries",
      "extractCut": true
    },
    {
      "id": "sec-042-case-32-testing-a-new-hiv-vaccine",
      "number": null,
      "title": "Case 32. Testing a new HIV vaccine",
      "level": 2,
      "pageStart": 112,
      "pageEnd": 114,
      "labelStart": "110",
      "labelEnd": "112",
      "words": 922,
      "summary": {
        "text": "Case 32, set in the 1990s, describes a northern European company's planned phase III placebo-controlled trial of an HIV vaccine among intravenous drug users in a South-East Asian country, with the company providing the vaccine, equipment, computers and vehicles, and seroconverters treated under ministry standards that excluded antiretroviral drugs. Consent was a two-stage process with tests of understanding, and the protocol was approved by several ethics review bodies. An AIDS activist group condemned the lack of state-of-the-art care, while the company argued that such care would be unsustainable and an unfair inducement, and the questions ask whether the study was ethical and consider compromise positions, other services for drug users, the company's gifts and whether a local sponsor would change the assessment.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hiv vaccine",
          "heading": true
        },
        {
          "term": "pharmaceutical company",
          "heading": false
        },
        {
          "term": "south-east asian",
          "heading": false
        },
        {
          "term": "vaccine institute",
          "heading": false
        },
        {
          "term": "asian country",
          "heading": false
        },
        {
          "term": "intravenous drug",
          "heading": false
        },
        {
          "term": "study proposal",
          "heading": false
        },
        {
          "term": "vidavax",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Standard of Care This case is based on research conducted in the 1990s when antiretroviral drugs were not generally available in most developing countries and the standard of care described here was the prevailing standard. In 1998, Vidavax, a pharmaceutical company based in northern Europe, developed an HIV vaccine that appeared",
      "extractCut": true
    },
    {
      "id": "sec-043-case-33-short-course-antiretroviral-therapy-in-p",
      "number": null,
      "title": "Case 33. Short-course antiretroviral therapy in pregnant women",
      "level": 2,
      "pageStart": 114,
      "pageEnd": 115,
      "labelStart": "112",
      "labelEnd": "113",
      "words": 508,
      "summary": {
        "text": "Case 33 describes a European institute's trial in southern Africa of a single-dose antiretroviral regimen to prevent mother-to-child HIV transmission, whose results led WHO to endorse the drug, although later re-examination found Good Clinical Practice lapses that left too weak a basis for European licensing. An east African regulator first refused a licence because the drug was not licensed in its country of manufacture but later gave way to international pressure, and the questions ask about the relevance of the European view, other options for the regulator and WHO's role.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pregnant women",
          "heading": true
        },
        {
          "term": "regulatory authority",
          "heading": false
        },
        {
          "term": "european regulatory",
          "heading": false
        },
        {
          "term": "short-course",
          "heading": true
        },
        {
          "term": "drug regulatory",
          "heading": false
        },
        {
          "term": "east african",
          "heading": false
        },
        {
          "term": "gcp",
          "heading": false
        },
        {
          "term": "european institute",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Standard of Care Viraret is an antiretroviral drug that is manufactured in Europe. A study in a southern African country was under- taken to test the efficacy of the drug for prevention of vertical transmission of HIV when given in an innovative, short-course (one dose) regimen to pregnant women who were HIV-positive. The study, which",
      "extractCut": true
    },
    {
      "id": "sec-044-case-34-use-of-quinacrine-for-non-surgical-steri",
      "number": null,
      "title": "Case 34. Use of quinacrine for non-surgical sterilization",
      "level": 2,
      "pageStart": 115,
      "pageEnd": 117,
      "labelStart": "113",
      "labelEnd": "115",
      "words": 972,
      "summary": {
        "text": "Case 34 examines decades of intrauterine use of quinacrine pellets for non-surgical female sterilization, promoted as cheap and simple and used in about 104 500 women in more than 20 countries, although never approved for this purpose anywhere. It traces research since the 1960s, cancer and mutagenicity concerns that led an NGO to withdraw and leading health organizations to advise against its use, and criticism by women's groups of experimentation without adequate toxicology data or informed choice. It ends with the halt of manufacture and distribution and asks whether double standards on drug safety in contraception can be justified and who should decide.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "non-surgical sterilization",
          "heading": true
        },
        {
          "term": "quinacrine",
          "heading": true
        },
        {
          "term": "quinacrine pellets",
          "heading": false
        },
        {
          "term": "quinacrine research",
          "heading": false
        },
        {
          "term": "steri lization",
          "heading": false
        },
        {
          "term": "fallopian tubes",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        },
        {
          "term": "ethical issues",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Standard of Care ❚ Although this case is based on research that occurred more than a decade ago, the issues raised by the case remain relevant.1 Little access to, and widespread non-compliance with, exist- ing methods of contraception have led to a large unmet need for better options for family planning, especially in developing",
      "extractCut": true
    },
    {
      "id": "sec-045-case-35-investigation-of-vaginal-microbicides",
      "number": null,
      "title": "Case 35. Investigation of vaginal microbicides",
      "level": 2,
      "pageStart": 117,
      "pageEnd": 119,
      "labelStart": "115",
      "labelEnd": "117",
      "words": 673,
      "summary": {
        "text": "Case 35 describes a foreign-funded randomized trial of a vaginal microbicide to prevent HIV in women at East African family-planning clinics, where patients normally pay for medicines and Pap smears are unavailable. Participants would receive free STI testing and treatment, yearly Pap smears and care for unrelated illnesses during the three-year trial, but the protocol does not state whether such care would continue afterwards. An ethics committee member fears this level of care may be an unfair inducement, while women excluded from earlier trials have complained of missing out, and the questions ask how to define unfair inducement and whether the study should go ahead in that country.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaginal microbicides",
          "heading": true
        },
        {
          "term": "unfair inducement",
          "heading": false
        },
        {
          "term": "family-planning clinics",
          "heading": false
        },
        {
          "term": "cervical cancer",
          "heading": false
        },
        {
          "term": "case study",
          "heading": false
        },
        {
          "term": "hiv transmission",
          "heading": false
        },
        {
          "term": "vagina",
          "heading": false
        },
        {
          "term": "smears",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Standard of Care ❚ An east African country has a scattered network of commu- nity family-planning clinics that provide free access to family-planning methods, maternity-related services, and some diagnosis and care for sexually transmitted infections (STIs); however, patients must pay for any medications, and physicians at these clinics",
      "extractCut": true
    },
    {
      "id": "sec-046-chapter-vi-obligations-to-participants-and-commu",
      "number": null,
      "title": "Chapter VI Obligations to Participants and Communities",
      "level": 1,
      "pageStart": 119,
      "pageEnd": 126,
      "labelStart": "117",
      "labelEnd": "124",
      "words": 3275,
      "summary": {
        "text": "Introduces Chapter VI on what researchers and sponsors owe to participants and host communities, describing research as a partnership whose obligations should be clear from the outset. It stresses that this matters most in countries with weak health systems, where a trial may be people's only chance of care and researchers may be expected to treat them. It lists possible obligations, such as care for people excluded from or leaving trials, compensation for injury, continued treatment after a study, help with unrelated illnesses and for family members, and access to results and proven products, and asks how far the principles of beneficence and nonmaleficence should reach. Annotated readings at the end cover care and treatment in vaccine trials and whether post-trial provision of beneficial interventions should be mandatory in developing countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "obligations",
          "heading": true
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "studies obligations",
          "heading": false
        },
        {
          "term": "ethical obligation",
          "heading": false
        },
        {
          "term": "research ers",
          "heading": false
        },
        {
          "term": "communities",
          "heading": true
        },
        {
          "term": "research study",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        }
      ],
      "extract": "Obligations to Participants and Communities © WHO 118 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Health research is increasingly understood as a partnership between interested stakeholders – potential and actual volun- teers and their communities, funders, sponsors, researchers, and health systems. In order for such a partnership to",
      "extractCut": true
    },
    {
      "id": "sec-047-case-36-observational-study-of-cervical-cancer",
      "number": null,
      "title": "Case 36. Observational study of cervical cancer",
      "level": 2,
      "pageStart": 126,
      "pageEnd": 128,
      "labelStart": "124",
      "labelEnd": "126",
      "words": 1088,
      "summary": {
        "text": "Presents a case, based on 1970s research, of an observational study funded by a South Asian country's medical research council to learn which cervical dysplasias progress to cancer, in order to design national control guidelines. At eight busy government hospitals, mostly illiterate women gave verbal consent to Pap smears without being told their lesions might become cancerous or that treatment existed, and those with dysplasia were followed every three months until carcinoma in situ before referral to an overloaded cancer centre. The study continued after a published longitudinal study showed all dysplasia warranted treatment, 71 women developed cancer, nine with spread, none were treated afterwards, and the case raises questions about justification, post-study care, duties arising from diagnosis, interim review, stopping rules and publication.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cervical cancer",
          "heading": true
        },
        {
          "term": "cervical dysplasia",
          "heading": false
        },
        {
          "term": "observational study",
          "heading": true
        },
        {
          "term": "pap smear",
          "heading": false
        },
        {
          "term": "precancerous lesion",
          "heading": false
        },
        {
          "term": "cancer centre",
          "heading": false
        },
        {
          "term": "regional cancer",
          "heading": false
        },
        {
          "term": "become cancerous",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Although this case study is based on research that took place in the 1970s, the questions that it raises remain relevant today. Cervical cancer causes at least 273 000 deaths globally every year, and about 85% of these deaths occur in developing coun- tries. The incidence of invasive cervical",
      "extractCut": true
    },
    {
      "id": "sec-048-case-37-testing-a-malaria-vaccine",
      "number": null,
      "title": "Case 37. Testing a malaria vaccine",
      "level": 2,
      "pageStart": 128,
      "pageEnd": 130,
      "labelStart": "126",
      "labelEnd": "128",
      "words": 1000,
      "summary": {
        "text": "Presents a case in which a multinational company plans, with scientists from an east African country, a placebo-controlled trial of a new malaria vaccine in children under five in a village with intense year-round transmission. Mothers would be recruited at a maternal and child health clinic with busy nurses helping with translation and consent checked by a standard questionnaire, while infected children would receive chloroquine under national guidelines despite 60% local resistance. Health officials object that consent is inadequate given female literacy below 40% and ask for free vaccine for all the country's children for five years if it works, which the company calls excessive, and the case asks about the ethics, the consent process, treatment and duties to the wider population.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "malaria vaccine",
          "heading": true
        },
        {
          "term": "falciparum malaria",
          "heading": false
        },
        {
          "term": "protozoan parasite",
          "heading": false
        },
        {
          "term": "pharmaceutical company",
          "heading": false
        },
        {
          "term": "mch clinic",
          "heading": false
        },
        {
          "term": "anopheles mosquitoes",
          "heading": false
        },
        {
          "term": "clinic nurses",
          "heading": false
        },
        {
          "term": "chloroquine",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities A multinational pharmaceutical company has developed a new malaria vaccine that has been successfully tested in Phase I and II trials. The company commissions a team of investigators to conduct a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of the vaccine in",
      "extractCut": true
    },
    {
      "id": "sec-049-case-38-mental-health-problems-of-survivors-of-m",
      "number": null,
      "title": "Case 38. Mental health problems of survivors of mass violence",
      "level": 2,
      "pageStart": 130,
      "pageEnd": 132,
      "labelStart": "128",
      "labelEnd": "130",
      "words": 954,
      "summary": {
        "text": "Presents a case of a European university clinic treating mostly South-East Asian refugees, which plans a study of internally displaced people in the refugees' home country to develop a culturally specific diagnostic scale for post-traumatic stress disorder. The researchers, with little local experience or language, would use paid community health workers as interpreters and ethnographers, conduct anonymous one-hour home interviews about violence and trauma after verbal consent, and refer high-risk people to a government health centre visited by a psychiatrist one day a month. No services are offered and results go to the psychiatrist and ministry, and the case asks whether an ethics committee concerned about emotional upset should approve it, who benefits, whether CIOMS Guideline 5 on informing participants is met and whether referral care should be assessed or upgraded.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "mental health",
          "heading": true
        },
        {
          "term": "mass violence",
          "heading": true
        },
        {
          "term": "mental illness",
          "heading": false
        },
        {
          "term": "displaced people",
          "heading": false
        },
        {
          "term": "refugees",
          "heading": false
        },
        {
          "term": "south-east asian",
          "heading": false
        },
        {
          "term": "informed consent",
          "heading": false
        },
        {
          "term": "principal researcher",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Many developed countries receive a large number of refu- gees seeking legal asylum. Most of these countries have basic mental health programmes which address the psychologi- cal needs of refugees. Most of those programmes, however, are at the local level and in most countries there has been",
      "extractCut": true
    },
    {
      "id": "sec-050-case-39-a-longitudinal-study-of-rotavirus-incide",
      "number": null,
      "title": "Case 39. A longitudinal study of rotavirus incidence among young children",
      "level": 2,
      "pageStart": 132,
      "pageEnd": 134,
      "labelStart": "130",
      "labelEnd": "132",
      "words": 837,
      "summary": {
        "text": "Presents a case of a longitudinal, community-based study of rotavirus incidence among children under two in a densely populated, poor inner-city area of a West African city, designed by a local medical university with North American epidemiologists who fund it. A cohort of 150 infants recruited at a general hospital with oral, witnessed consent is followed for two years with cord blood, stool samples and home and monthly clinic visits. Participants receive free medical care for the child and family, antimalarial prophylaxis and transport money, all ending with the study, and the case asks how these benefits affect enrolment and outcomes, whether they should continue and whether investigators must ensure the ministry uses the findings.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "rotavirus",
          "heading": true
        },
        {
          "term": "longitudinal study",
          "heading": true
        },
        {
          "term": "among children",
          "heading": true
        },
        {
          "term": "rotavirus infection",
          "heading": false
        },
        {
          "term": "research assistants",
          "heading": false
        },
        {
          "term": "inner core",
          "heading": false
        },
        {
          "term": "clinic visit",
          "heading": false
        },
        {
          "term": "children younger",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Acute diarrhoeal disease is a leading cause of death in children younger than 5 years in developing countries, and infants younger than 2 years are particularly susceptible. However, few prospective, community-based studies have documented the incidence and cause of diarrhoeal disease among",
      "extractCut": true
    },
    {
      "id": "sec-051-case-40-testing-a-vaccine-for-childhood-cholera",
      "number": null,
      "title": "Case 40. Testing a vaccine for childhood cholera",
      "level": 2,
      "pageStart": 134,
      "pageEnd": 135,
      "labelStart": "132",
      "labelEnd": "133",
      "words": 708,
      "summary": {
        "text": "Presents a case of a South-East Asian research institute testing a new three-dose vaccine against Vibrio cholerae O139 in children under five in a rural area of about 75 000 people, where the government clinic lacks medicines and cholera cots and health spending is 5 US dollars per person a year. Because the comparison group receives a tetanus toxoid booster and is more likely to get cholera, the institute plans a free state-of-the-art treatment facility, although some propose upgrading the government clinic instead. As the institute relies on grants and fears an unaffordable long-term commitment, the case asks who should pay for continuing care, what messages should accompany vaccination and whether participants and other citizens should receive free vaccine if it works.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cholera",
          "heading": true
        },
        {
          "term": "cholera cots",
          "heading": false
        },
        {
          "term": "tetanus toxoid",
          "heading": false
        },
        {
          "term": "vaccine",
          "heading": true
        },
        {
          "term": "government clinic",
          "heading": false
        },
        {
          "term": "treatment facility",
          "heading": false
        },
        {
          "term": "research centre",
          "heading": false
        },
        {
          "term": "ort",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Cholera is an acute intestinal infection which causes watery diarrhoea. If left untreated, cholera can result very quickly in severe dehydration and even death. The disease is endemic in certain regions of South and South-East Asia, placing young children at high risk of death from a very",
      "extractCut": true
    },
    {
      "id": "sec-052-case-41-impact-of-civil-war-on-health-systems",
      "number": null,
      "title": "Case 41. Impact of civil war on health systems",
      "level": 2,
      "pageStart": 135,
      "pageEnd": 136,
      "labelStart": "133",
      "labelEnd": "134",
      "words": 427,
      "summary": {
        "text": "Presents a case of health ministry researchers in a sub-Saharan African country studying how armed conflict affects the health system, using focus groups with internally displaced people and host community members and interviews with leaders, officials and aid agency staff. Camps are chosen by district officials, participants are recruited by self-appointed community leaders, results go to officials who must relay them, no compensation is given, and the case asks about leader-led recruitment, duties to share results and mixing displaced and host community members in one group.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "idp camps",
          "heading": false
        },
        {
          "term": "armed conflict",
          "heading": false
        },
        {
          "term": "health systems",
          "heading": true
        },
        {
          "term": "host communi",
          "heading": false
        },
        {
          "term": "communi ties",
          "heading": false
        },
        {
          "term": "community leaders",
          "heading": false
        },
        {
          "term": "war",
          "heading": true
        },
        {
          "term": "focus group",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Obligations to Participants and Communities ❚ Effective control of malaria is heavily dependent on a func- tioning health care system (i.e. drug distribution, information systems, and preventive, curative, and referral systems). In some of the countries in greatest need of malaria control, however, armed conflict has severely disrupted",
      "extractCut": true
    },
    {
      "id": "sec-053-case-42-determining-who-constitutes-the-communit",
      "number": null,
      "title": "Case 42. Determining who constitutes the community",
      "level": 2,
      "pageStart": 136,
      "pageEnd": 138,
      "labelStart": "134",
      "labelEnd": "136",
      "words": 939,
      "summary": {
        "text": "Presents a case from a South Asian agricultural district where tribal people, mostly landless and living in outlying hamlets, are excluded from local power, and government health services have declined while private care is costly. A public-sector health company proposes hospital user charges, and a multilateral lender requires a participatory study in which focus group members are chosen by village committees and meet in the main village temple, finding willingness to pay if quality improves. During a gastroenteritis outbreak, field researchers meet angry tribal residents and find that under 10% of participants had tribal names, but the principal investigator dismisses their concerns, and the case asks about participant selection, who represents a community, duties toward minorities and the sponsors' obligations.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "tribal people",
          "heading": false
        },
        {
          "term": "popu lation",
          "heading": false
        },
        {
          "term": "main village",
          "heading": false
        },
        {
          "term": "research team",
          "heading": false
        },
        {
          "term": "government services",
          "heading": false
        },
        {
          "term": "studies obligations",
          "heading": false
        },
        {
          "term": "community",
          "heading": true
        },
        {
          "term": "farmers",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities An agricultural district in a South Asian country has a popu- lation that is 30% tribal. The tribal population of this district comprises 80% of the landless poor in the country, and most live in small hamlets that are 2-3 km from the main village in the district. Only about 10% of the tribal",
      "extractCut": true
    },
    {
      "id": "sec-054-case-43-evaluation-research-on-a-disability-reha",
      "number": null,
      "title": "Case 43. Evaluation research on a disability rehabilitation programme",
      "level": 2,
      "pageStart": 138,
      "pageEnd": 140,
      "labelStart": "136",
      "labelEnd": "138",
      "words": 764,
      "summary": {
        "text": "Presents a case from a poor South Asian democracy where a right-to-education law covers disabled children and a national programme funds voluntary organizations 100 US dollars a year per disabled child counted by the census. A paediatrician-evaluator finds a model district's programme efficient and popular, but a new probing survey reveals many severely disabled, bedridden children missed by the census who are malnourished and lack medical care or rehabilitation. The district collector urges him to stay quiet to protect the programme, the census and the budget, while the expert believes he must expose the systematic bias, and the case asks whether he should publish, whether ethics review was needed and who is at risk in health system evaluations.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "disabled children",
          "heading": false
        },
        {
          "term": "disability",
          "heading": true
        },
        {
          "term": "rehabilitation",
          "heading": true
        },
        {
          "term": "programme",
          "heading": true
        },
        {
          "term": "census",
          "heading": false
        },
        {
          "term": "research",
          "heading": true
        },
        {
          "term": "evaluation",
          "heading": true
        },
        {
          "term": "studies obligations",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities Child-rights groups in a poor democratic country in South Asia have successfully campaigned to make elementary education for all children between the ages of 6 and 14 years a fundamental, justiciable right. The campaign included several groups working in the area of disability, and the",
      "extractCut": true
    },
    {
      "id": "sec-055-case-44-clinical-benefits-of-an-immune-modifying",
      "number": null,
      "title": "Case 44. Clinical benefits of an immune-modifying supplement in HIV therapy",
      "level": 2,
      "pageStart": 140,
      "pageEnd": 141,
      "labelStart": "138",
      "labelEnd": "139",
      "words": 650,
      "summary": {
        "text": "Presents a casebook case about a large US trial, funded by a drug company, of an immune-modifying drug added to standard HIV treatment, which an independent board stopped early after finding no clinical benefit. The company then claimed a positive effect, withheld the final data unless its own analyses were included and sought to approve publications, so the researchers published using about 95% of the data. The company sued the lead researcher's university, and the case asks who owns study data and whether sponsors may block publication of results.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pharmaceutical company",
          "heading": false
        },
        {
          "term": "immune-modifying",
          "heading": true
        },
        {
          "term": "clinical benefits",
          "heading": true
        },
        {
          "term": "researchers believed",
          "heading": false
        },
        {
          "term": "researchers agreed",
          "heading": false
        },
        {
          "term": "pre-study agreement",
          "heading": false
        },
        {
          "term": "experimental drug",
          "heading": false
        },
        {
          "term": "clinical trial",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Obligations to Participants and Communities In 1995, two professors from prominent North American universities organized the largest randomized drug trial of the past decade in HIV-infected people. With a nationwide team of investigators, they evaluated the clinical benefits of an immune-modifying drug that was intended to supple- ment",
      "extractCut": true
    },
    {
      "id": "sec-056-case-45-genetic-research-on-an-island-population",
      "number": null,
      "title": "Case 45. Genetic research on an island population",
      "level": 2,
      "pageStart": 141,
      "pageEnd": 143,
      "labelStart": "139",
      "labelEnd": "141",
      "words": 794,
      "summary": {
        "text": "Case 45 describes a 2001 agreement between a European biotechnology firm and the government of a genetically homogeneous island nation of about 90 000 people with high diabetes rates, under which the firm would sample families with diabetes to search for disease genes. The company promised funding to the health ministry, a new research centre and a share of royalties, but community groups, the democracy movement and the churches objected to the lack of public debate, privacy protection and benefit guarantees and to the patenting of life forms, and the firm withdrew. The questions ask whether a population collectively owns its genetic heritage, how governments should negotiate such deals, how benefit-sharing can be judged fair, and whether a non-profit sponsor would change the ethical picture.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "island population",
          "heading": true
        },
        {
          "term": "genetic research",
          "heading": true
        },
        {
          "term": "genetic analysis",
          "heading": false
        },
        {
          "term": "company",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "years ago",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "life forms",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Obligations to Participants and Communities ❚ An island nation has a population of about 90 000, all of whom are of a single ethnic background. There is little or no immigration to the island and hence the genetic make-up of the population is quite homogenous.This presumed genetic homogeneity along with the high incidence of certain",
      "extractCut": true
    },
    {
      "id": "sec-057-chapter-vii-privacy-and-confidentiality",
      "number": null,
      "title": "Chapter VII Privacy and Confidentiality",
      "level": 1,
      "pageStart": 143,
      "pageEnd": 148,
      "labelStart": "141",
      "labelEnd": "146",
      "words": 2270,
      "summary": {
        "text": "Opens the chapter on privacy and confidentiality in a casebook on ethical issues in international health research, contrasting privacy as an interest of individuals or groups with confidentiality as a professional duty. It outlines three kinds of privacy interest (control over access to information, over being observed, and over personal decisions) and notes that what counts as an intrusion differs between cultures. It explains why both tangible interests, such as employment or insurance, and intangible ones, such as dignity and the shaping of relationships, deserve protection, and how research ethics committees should weigh risks against the value of the knowledge sought. The section ends by warning that whole communities can be stigmatized by research findings or by disclosing study sites, followed by suggested readings on returning individual results and on data protection.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "privacy",
          "heading": true
        },
        {
          "term": "confidentiality",
          "heading": true
        },
        {
          "term": "intangible interests",
          "heading": false
        },
        {
          "term": "studies privacy",
          "heading": false
        },
        {
          "term": "research participants",
          "heading": false
        },
        {
          "term": "partici pants",
          "heading": false
        },
        {
          "term": "tangible harms",
          "heading": false
        },
        {
          "term": "genetic databanks",
          "heading": false
        }
      ],
      "extract": "Privacy and Confidentiality © WHO 142 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Privacy and Conﬁdentiality Privacy and confidentiality – the first an interest or right of either individuals or small groups of people, and the second a duty of professionals – might be jeopardized by health research. When privacy and confidentiality can be fully protected without the scientific",
      "extractCut": true
    },
    {
      "id": "sec-058-case-46-studying-nevirapine-in-west-africa",
      "number": null,
      "title": "Case 46. Studying Nevirapine in West Africa",
      "level": 2,
      "pageStart": 148,
      "pageEnd": 149,
      "labelStart": "146",
      "labelEnd": "147",
      "words": 355,
      "summary": {
        "text": "Presents a case from a West African study of nevirapine to prevent perinatal HIV transmission, in which an HIV-positive woman, one of several wives, refuses to let the doctor tell her husband for fear of being expelled or harmed. Colleagues disagree on whether the promised confidentiality should be broken, and the questions ask whether the husband or other partners should be told and whether a safety plan is owed to the woman.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "nevirapine",
          "heading": true
        },
        {
          "term": "doctor tells",
          "heading": false
        },
        {
          "term": "west",
          "heading": true
        },
        {
          "term": "husband",
          "heading": false
        },
        {
          "term": "honoured",
          "heading": false
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "studying",
          "heading": true
        },
        {
          "term": "ethical issues",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Privacy and Conﬁdentiality A study in a West African country is designed to examine the effectiveness of the antiretroviral drug, Nevirapine, when administered to HIV-positive women during labour and then to their newborns for the first three months after birth. The aim of the study is to assess whether Nevirapine can reduce the",
      "extractCut": true
    },
    {
      "id": "sec-059-case-47-the-quality-of-care-in-a-family-welfare",
      "number": null,
      "title": "Case 47. The quality of care in a family welfare programme",
      "level": 2,
      "pageStart": 149,
      "pageEnd": 150,
      "labelStart": "147",
      "labelEnd": "148",
      "words": 478,
      "summary": {
        "text": "Presents a case on evaluating care in a South Asian family welfare programme, where an ethics board required that primary health centres and staff not be identifiable, and a field researcher saw syringes being reused. After she reported it anonymously to a supervisor, she saw the same practice a week later, and the questions ask whether confidentiality should be strictly upheld and what the principal investigator should do.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "phcs",
          "heading": false
        },
        {
          "term": "field researcher",
          "heading": false
        },
        {
          "term": "reusing syringes",
          "heading": false
        },
        {
          "term": "principal investigator",
          "heading": false
        },
        {
          "term": "state government",
          "heading": false
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "case study",
          "heading": false
        },
        {
          "term": "mentioning",
          "heading": false
        }
      ],
      "extract": "in one of the states of a South Asian country. The project is funded by a grant from a European university to the South Asian university which employs the researchers. As part of the evaluation process, the investigators plan to interview the doctors, supervisors, and multipurpose health workers employed at selected primary health centres (PHCs) in the state, and the family-planning clients who visit those PHCs.",
      "extractCut": true
    },
    {
      "id": "sec-060-case-48-responding-when-study-findings-are-chall",
      "number": null,
      "title": "Case 48. Responding when study findings are challenged",
      "level": 2,
      "pageStart": 150,
      "pageEnd": 151,
      "labelStart": "148",
      "labelEnd": "149",
      "words": 500,
      "summary": {
        "text": "Presents a related case in which researchers who found widely varying quality of care, and poor conditions at sterilization camps, in a South Asian state's primary health centres refused officials' demands to name the centres, citing the agreed anonymity. Officials accused them of fabricating evidence and argued confidentiality did not apply, and the questions ask whether the centres should be named and when confidentiality promises may be set aside.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "phcs",
          "heading": false
        },
        {
          "term": "study findings",
          "heading": true
        },
        {
          "term": "case study",
          "heading": true
        },
        {
          "term": "health officials",
          "heading": false
        },
        {
          "term": "camps",
          "heading": false
        },
        {
          "term": "challenged",
          "heading": true
        },
        {
          "term": "researchers",
          "heading": false
        },
        {
          "term": "employees",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Privacy and Conﬁdentiality A team of university researchers have completed an evalua- tion of the quality of care in a family welfare programme of a state in a South Asian country. The researchers complied with the recommendations of a research ethics committee that they should ensure the confidentiality of all identifying data about",
      "extractCut": true
    },
    {
      "id": "sec-061-case-49-determining-post-abortion-complication-l",
      "number": null,
      "title": "Case 49. Determining post-abortion complication levels",
      "level": 2,
      "pageStart": 151,
      "pageEnd": 153,
      "labelStart": "149",
      "labelEnd": "151",
      "words": 930,
      "summary": {
        "text": "Presents a case on a study in an Eastern European country, where many abortions still occur outside legal centres, designed to measure post-abortion complications and link them to the type of provider across 140 villages. Women are found through providers, community health workers and women's groups, give oral consent, and are interviewed at home with safeguards such as dummy interviews, a focus on general gynaecological health and artificial privacy. One member of the funder's ethics committee doubts that identifying records will stay confidential, and the questions ask whether recruitment, oral consent and the interview methods adequately protect privacy and avoid coercion.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "abortion seekers",
          "heading": false
        },
        {
          "term": "abortion centres",
          "heading": false
        },
        {
          "term": "dummy interviews",
          "heading": false
        },
        {
          "term": "abortion services",
          "heading": false
        },
        {
          "term": "post-abortion",
          "heading": true
        },
        {
          "term": "women groups",
          "heading": false
        },
        {
          "term": "oral consent",
          "heading": false
        },
        {
          "term": "studies privacy",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Privacy and Conﬁdentiality ❚ An eastern European country has passed a law to make abortion legal for a range of social and medical indications. Nevertheless, legal abortion centres are neither geographi- cally accessible, nor always functioning effectively. Indeed, abortions outside of the legally recognized sector are still estimated to",
      "extractCut": true
    },
    {
      "id": "sec-062-case-50-evaluating-the-cost-benefit-ratio-of-lon",
      "number": null,
      "title": "Case 50. Evaluating the cost-benefit ratio of long-term care services",
      "level": 2,
      "pageStart": 153,
      "pageEnd": 154,
      "labelStart": "151",
      "labelEnd": "152",
      "words": 450,
      "summary": {
        "text": "Presents a case in which a Central American mental health institute, seeking to compare the cost and benefit of long-term community care services, told centres to obtain patients' consent to release confidential psychiatric records and to reimburse care only for those who signed. Clinicians called this coercive and objected to government access to records, and the questions ask when state access to medical records is acceptable and what makes consent valid.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "long-term care",
          "heading": true
        },
        {
          "term": "care services",
          "heading": true
        },
        {
          "term": "consent forms",
          "heading": false
        },
        {
          "term": "receive long-term",
          "heading": false
        },
        {
          "term": "mental health",
          "heading": false
        },
        {
          "term": "institute",
          "heading": false
        },
        {
          "term": "cost-benefit",
          "heading": true
        },
        {
          "term": "reimburse",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Privacy and Conﬁdentiality ❚ The mental health institute of a Central American country has historically offered financial support to community mental health centres (CMHCs) that provide care for people who have severe, chronic mental illness (including most individuals with schizophrenia, and many who suffer from manic-depressive illness",
      "extractCut": true
    },
    {
      "id": "sec-063-case-51-research-on-an-identifiable-population",
      "number": null,
      "title": "Case 51. Research on an identifiable population",
      "level": 2,
      "pageStart": 154,
      "pageEnd": 155,
      "labelStart": "152",
      "labelEnd": "153",
      "words": 487,
      "summary": {
        "text": "Presents a case in which researchers plan to study a genetic link between brainwave patterns and alcoholism in 300 families of a North American indigenous tribe, offering payment, and many individuals want to take part. A tribal representative body urges the ethics committee to reject the study for lack of consultation, disregard for beliefs about the sacredness of blood and the risk of stigma, and the questions ask how the committee should weigh community and individual views.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "alcoholism",
          "heading": false
        },
        {
          "term": "tribal community",
          "heading": false
        },
        {
          "term": "research",
          "heading": true
        },
        {
          "term": "representative body",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "preliminary survey",
          "heading": false
        },
        {
          "term": "xxx",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Privacy and Conﬁdentiality A team of molecular biology researchers wishes to study the basis of alcoholism in selected native peoples of North America. This research is based on reports of a significant correlation between alcoholism and several forms of brain- wave activity that are measurable by electroencephalography: Caucasian and",
      "extractCut": true
    },
    {
      "id": "sec-064-case-52-case-control-study-of-vasectomy-and-pros",
      "number": null,
      "title": "Case 52. Case-control study of vasectomy and prostate cancer",
      "level": 2,
      "pageStart": 155,
      "pageEnd": 156,
      "labelStart": "153",
      "labelEnd": "154",
      "words": 392,
      "summary": {
        "text": "Presents a case-control study in an industrialized country on vasectomy and prostate cancer, in which cases are identified from clinicians' records, controls are drawn from the electoral register, and participants are interviewed by telephone. To avoid bias, men would be told only that the study concerns risk factors for prostate disease, and the questions ask whether record access without permission, telephone consent and withholding the study's purpose are acceptable.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "prostate cancer",
          "heading": true
        },
        {
          "term": "case-control study",
          "heading": true
        },
        {
          "term": "vasectomy",
          "heading": true
        },
        {
          "term": "telephone interviews",
          "heading": false
        },
        {
          "term": "premise",
          "heading": false
        },
        {
          "term": "biased",
          "heading": false
        },
        {
          "term": "acceptable",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Privacy and Conﬁdentiality ❚ Epidemiologists in an industrialized country propose to investigate the association between vasectomy and adeno- carcinoma1 of the prostate gland, using a case-control study design. Men with prostate cancer, confirmed by histologi- cal examination, will be identified through their clinicians’ records. The",
      "extractCut": true
    },
    {
      "id": "sec-065-case-53-studying-health-seeking-behaviour",
      "number": null,
      "title": "Case 53. Studying health-seeking behaviour",
      "level": 2,
      "pageStart": 156,
      "pageEnd": 157,
      "labelStart": "154",
      "labelEnd": "155",
      "words": 457,
      "summary": {
        "text": "Presents a case in which social scientists, with hospital permission, use records to find women with positive Pap tests who did not return for results, visit them at home, give them their results and refer them directly to physicians. They justify this by the health benefits and the hospital's ownership of records, and the questions ask whether confidentiality is breached and how else the problem could have been approached.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "social scientists",
          "heading": false
        },
        {
          "term": "pap test",
          "heading": false
        },
        {
          "term": "cervical cancer",
          "heading": false
        },
        {
          "term": "grant permission",
          "heading": false
        },
        {
          "term": "women health",
          "heading": false
        },
        {
          "term": "health-seeking",
          "heading": true
        },
        {
          "term": "studying",
          "heading": true
        },
        {
          "term": "hospital",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Privacy and Conﬁdentiality A team of social scientists concerned with improvement of women’s health wants to learn why women do not return to the hospital for the results of Papanicolaou (Pap) tests.1 They have a research project to follow up with women who have a presumptive diagnosis of cervical cancer (a positive Pap test) but who do",
      "extractCut": true
    },
    {
      "id": "sec-066-case-54-health-promotion-survey-research-on-a-co",
      "number": null,
      "title": "Case 54. Health promotion survey research on a commercial farm",
      "level": 2,
      "pageStart": 157,
      "pageEnd": 159,
      "labelStart": "155",
      "labelEnd": "157",
      "words": 809,
      "summary": {
        "text": "Presents a case set on a commercial farm in southern Africa, where mostly male migrant seasonal workers live in compounds with few women, and health promotion researchers returned for a follow-up survey after agreeing their role with management and workers. Mapping showed hidden sexual contact between migrant men and local women, and registration revealed that about 8% of workers were under 16, most of them local girls aged 8 to 15. The researchers feared these girls faced sexually transmitted infections including HIV and were missing school, and the questions ask whether they should inform management and what obligations they have to protect participants.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "farm",
          "heading": true
        },
        {
          "term": "farm compounds",
          "heading": false
        },
        {
          "term": "farm workers",
          "heading": false
        },
        {
          "term": "farm management",
          "heading": false
        },
        {
          "term": "seasonal labourers",
          "heading": false
        },
        {
          "term": "migrant men",
          "heading": false
        },
        {
          "term": "health promotion",
          "heading": true
        },
        {
          "term": "health research",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Privacy and Conﬁdentiality ❚ A large farm in southern Africa recruits both men and women as seasonal labourers from the nearby town, local villages and other rural areas. The male-female ratio among the seasonal labourers is approximately four to one, although other women are involved informally in the economy of the farm selling",
      "extractCut": true
    },
    {
      "id": "sec-067-case-55-interviewing-child-domestic-helpers-in-s",
      "number": null,
      "title": "Case 55. Interviewing child domestic helpers in sub-Saharan Africa",
      "level": 2,
      "pageStart": 159,
      "pageEnd": 161,
      "labelStart": "157",
      "labelEnd": "159",
      "words": 586,
      "summary": {
        "text": "Presents Case 55, a questionnaire study of reproductive health problems among girls aged 13–17 who live away from home as domestic workers in sub-Saharan Africa, set against the background of child fosterage being misused for trafficking. It describes how households are approached, how children give consent and are interviewed privately with a decoy questionnaire, contact details and compensation, and then asks whether privacy, safety and valid consent have been adequately addressed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "helpers",
          "heading": true
        },
        {
          "term": "house helpers",
          "heading": false
        },
        {
          "term": "domestic",
          "heading": true
        },
        {
          "term": "sub-saharan africa",
          "heading": true
        },
        {
          "term": "child",
          "heading": true
        },
        {
          "term": "domestic labour",
          "heading": false
        },
        {
          "term": "interviewers",
          "heading": false
        },
        {
          "term": "interviewing",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Privacy and Conﬁdentiality ❚ including the risk of harassment or a beating, the children will be interviewed in private. Each interviewer will have a separate “safe” questionnaire to revert to should the child’s “employer” enter the room unexpectedly, and the child will have been prepared for this possibility. The interviewers will give",
      "extractCut": true
    },
    {
      "id": "sec-068-chapter-viii-professional-ethics",
      "number": null,
      "title": "Chapter VIII Professional Ethics",
      "level": 1,
      "pageStart": 161,
      "pageEnd": 167,
      "labelStart": "159",
      "labelEnd": "165",
      "words": 2937,
      "summary": {
        "text": "Opens the chapter on professional ethics in a casebook on ethical issues in international health research, setting out what can fairly be expected of researchers, ethics committee members, sponsors and funders in terms of integrity and honesty. It focuses on two broad areas, conflicts of interest and scientific misconduct, defining a conflict of interest as a situation where personal gain could compromise duties to participants or to sound science, and separating this from the tension between patient care and good science. It explains how industry-funded research and scientists' financial ties to companies have made such conflicts widespread, and discusses concerns about commercial research ethics committees and fees charged by committees. The section closes with suggested readings on industry relationships, whistleblowing and cross-cultural views of scientific misconduct.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "professional ethics",
          "heading": true
        },
        {
          "term": "scientific misconduct",
          "heading": false
        },
        {
          "term": "research misconduct",
          "heading": false
        },
        {
          "term": "disclose conflicts",
          "heading": false
        },
        {
          "term": "chapter viii",
          "heading": true
        },
        {
          "term": "ethics committees",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "research involving",
          "heading": false
        }
      ],
      "extract": "Chapter VIII © WHO 160 CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics The expectation that researchers and other stakeholders in the research process – including ethics committee members, sponsors, and funders – will act with integrity and honesty is a fair one. When a research article is published, it is fair to expect, at the very least, that the data has not",
      "extractCut": true
    },
    {
      "id": "sec-069-case-56-testing-delivery-methods-for-a-hormonal",
      "number": null,
      "title": "Case 56. Testing delivery methods for a hormonal contraceptive",
      "level": 2,
      "pageStart": 167,
      "pageEnd": 168,
      "labelStart": "165",
      "labelEnd": "166",
      "words": 422,
      "summary": {
        "text": "Case 56 describes a manufacturer-sponsored trial comparing tablet, patch and injectable forms of a new hormonal contraceptive in women from two socioeconomic groups, with the company paying researchers' salaries, computers and a per-participant fee and giving volunteers a small payment. Questions ask about the appropriateness of these benefits, conflicts of interest, partner involvement in consent, infections acquired during the trial and the sponsor's obligations if the product fails.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hormonal contraceptive",
          "heading": true
        },
        {
          "term": "socioeconomic groups",
          "heading": false
        },
        {
          "term": "manufacturer",
          "heading": false
        },
        {
          "term": "delivery",
          "heading": true
        },
        {
          "term": "patches",
          "heading": false
        },
        {
          "term": "trial",
          "heading": false
        },
        {
          "term": "methods",
          "heading": true
        },
        {
          "term": "case",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Professional Ethics ❚ The manufacturer of a new hormonal contraceptive commis- sions a research team to design a clinical trial to compare the effectiveness and tolerability of the new preparation using three different methods of delivery – oral tablets, transder- mal patches, and injections. The manufacturer also wants the researchers to",
      "extractCut": true
    },
    {
      "id": "sec-070-case-57-testing-a-treatment-for-schizophrenia",
      "number": null,
      "title": "Case 57. Testing a treatment for schizophrenia",
      "level": 2,
      "pageStart": 168,
      "pageEnd": 169,
      "labelStart": "166",
      "labelEnd": "167",
      "words": 532,
      "summary": {
        "text": "Case 57 describes an Asian drug company that, after a regulator refused approval of its antipsychotic over heart rhythm problems, contracts an overcrowded eastern European psychiatric hospital to test it, with doctors paid per recruited patient and local regulators not told of the earlier refusal. Questions cover risk-benefit, disclosure duties across countries, ensuring capacity to consent, possible misconduct, recruiters' conflicts of interest and post-trial access.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "schizophrenia",
          "heading": true
        },
        {
          "term": "company",
          "heading": false
        },
        {
          "term": "regulatory agency",
          "heading": false
        },
        {
          "term": "ill patients",
          "heading": false
        },
        {
          "term": "earn",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "testing",
          "heading": true
        },
        {
          "term": "laws",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics An Asian pharmaceutical company has developed a prom- ising new antipsychotic medication for the treatment of schizophrenia.1 Sales analysts predict the drug could earn the company a substantial profit within four years. The study drug has already been tested on several thousand volunteers in Asia. During this",
      "extractCut": true
    },
    {
      "id": "sec-071-case-58-budget-reviews-by-research-ethics-commit",
      "number": null,
      "title": "Case 58. Budget reviews by research ethics committees",
      "level": 2,
      "pageStart": 169,
      "pageEnd": 170,
      "labelStart": "167",
      "labelEnd": "168",
      "words": 435,
      "summary": {
        "text": "Case 58 describes a research ethics committee at a South-East Asian medical school that refuses to review a large North American family planning study unless it sees the budget, while the North American university fears the school's 10% overhead could sway members who are also on the research team. Questions ask whether budget review belongs to an ethics committee, how any conflict of interest could be handled and how capacity-building benefits should be weighed.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "research ethics",
          "heading": true
        },
        {
          "term": "budget reviews",
          "heading": true
        },
        {
          "term": "research proposal",
          "heading": false
        },
        {
          "term": "north american",
          "heading": false
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "american university",
          "heading": false
        },
        {
          "term": "nusm",
          "heading": false
        },
        {
          "term": "johns hopkins",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Professional Ethics ❚ A major North American university has submitted a research proposal to the research ethics committee of the National University School of Medicine (NUSM) in a developing coun- try in South-East Asia. It is an ambitious proposal that carries with it a US$ 500 000 yearly budget to examine the efficacy of an innovative",
      "extractCut": true
    },
    {
      "id": "sec-072-case-59-determining-the-workforce-costs-of-the-a",
      "number": null,
      "title": "Case 59. Determining the workforce costs of the AIDS epidemic",
      "level": 2,
      "pageStart": 170,
      "pageEnd": 172,
      "labelStart": "168",
      "labelEnd": "170",
      "words": 1153,
      "summary": {
        "text": "Case 59 describes a European university team, fully funded by a west African mining company, studying the cost of AIDS to the company's workforce in the hope of prompting prevention programmes. A trade union official warns that the company may instead dismiss HIV-positive workers or downsize, and the company refuses to give written assurances. After the findings show rising health care costs, the chief executive asks the team to recommend capping HIV insurance benefits, and questions ask how researchers should guard against misuse of their data and respond to such pressure.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "aids epidemic",
          "heading": true
        },
        {
          "term": "company",
          "heading": false
        },
        {
          "term": "research team",
          "heading": false
        },
        {
          "term": "costs",
          "heading": true
        },
        {
          "term": "research associate",
          "heading": false
        },
        {
          "term": "employees",
          "heading": false
        },
        {
          "term": "health research",
          "heading": false
        },
        {
          "term": "care costs",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics The staff-benefits group of a west African mining company asks a research team based at a European university to help determine the economic impact of the AIDS epidemic on their workforce. The group wants to convince senior management that the cost is much higher than expected. They suspect that absenteeism due to",
      "extractCut": true
    },
    {
      "id": "sec-073-case-60-action-research-on-involuntary-resettlem",
      "number": null,
      "title": "Case 60. Action research on involuntary resettlement",
      "level": 2,
      "pageStart": 172,
      "pageEnd": 174,
      "labelStart": "170",
      "labelEnd": "172",
      "words": 796,
      "summary": {
        "text": "Case 60 describes a small NGO in a South Asian city that partners with a research organization to study how relocation from slums to a distant colony has affected people's health, education and livelihoods. The ethics committee bars recruiting case-study participants from the NGO's clinic users for fear they would feel coerced, so the team runs a random household survey, but by identifying with the NGO it faces pressure to give direct help and participants expect services. Questions concern the committee's decision, how far to meet community expectations, effects on informed consent and the tension between action and research.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "action research",
          "heading": true
        },
        {
          "term": "ngo staff",
          "heading": false
        },
        {
          "term": "local ngo",
          "heading": false
        },
        {
          "term": "research team",
          "heading": false
        },
        {
          "term": "resettlement",
          "heading": true
        },
        {
          "term": "involuntary",
          "heading": true
        },
        {
          "term": "ethics committee",
          "heading": false
        },
        {
          "term": "case",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics A small community-based NGO has been delivering a health programme in the slums of a large city in South Asia. Part of the slum’s population has been relocated to another colony, 15 km away, and the NGO has set up a clinic in this new colony. Based on their experience with the community both before and after",
      "extractCut": true
    },
    {
      "id": "sec-074-case-61-victimizing-the-system-or-a-victim-of-it",
      "number": null,
      "title": "Case 61. Victimizing the system or a victim of it?",
      "level": 2,
      "pageStart": 174,
      "pageEnd": 176,
      "labelStart": "172",
      "labelEnd": "174",
      "words": 842,
      "summary": {
        "text": "Case 61 describes a young research assistant who finds that a respected senior researcher altered data that contradicted their lab's hypothesis, and then uncovers a wider pattern of fabricated measurements and non-existent patients. Despite a colleague's warning that everyone will lose, she files a formal complaint, and an inquiry leads the researcher, a major grant earner, to plead guilty to falsifying a federal grant application after more than a decade of fraud. Questions ask whether his pleas for leniency are valid, how whistle-blowers should be treated and who should enforce scientific integrity.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "simpson",
          "heading": false
        },
        {
          "term": "victim",
          "heading": true
        },
        {
          "term": "she",
          "heading": false
        },
        {
          "term": "lee",
          "heading": false
        },
        {
          "term": "him",
          "heading": false
        },
        {
          "term": "jacobs",
          "heading": false
        },
        {
          "term": "victimizing",
          "heading": true
        },
        {
          "term": "professional ethics",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics Xue Lee, a 25-year-old research assistant with plans to go to medical school, has discovered that a set of data given to her by a much-admired senior researcher, Dr Simpson, does not support the working hypothesis of their lab, which is that the increased vulnerability to cardiovascular disease that accom- panies",
      "extractCut": true
    },
    {
      "id": "sec-075-case-62-truth-and-consequences",
      "number": null,
      "title": "Case 62. Truth and consequences",
      "level": 2,
      "pageStart": 176,
      "pageEnd": 177,
      "labelStart": "174",
      "labelEnd": "175",
      "words": 643,
      "summary": {
        "text": "Case 62 describes six genetics graduate students who suspect their professor of faking data, confront her, and after months of hesitation over the risk to their own research report her to the university. An investigation finds falsified grant applications and pressure on students to hide unwanted results, and after the professor resigns most students must restart their projects, leave or face years of delay. Questions ask whether they should have reported, what would have happened had they stayed silent and how universities should protect whistle-blowers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "prof kieros",
          "heading": false
        },
        {
          "term": "graduate students",
          "heading": false
        },
        {
          "term": "consequences",
          "heading": true
        },
        {
          "term": "heath",
          "heading": false
        },
        {
          "term": "university",
          "heading": false
        },
        {
          "term": "doctoral",
          "heading": false
        },
        {
          "term": "truth",
          "heading": true
        },
        {
          "term": "deans",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH ❚ THE CASE STUDIES ❚ Professional Ethics Six graduate students who work under Professor Maria Kieros in the department of genetics at a major university have reluctantly come to the conclusion that she has been faking data. This conclusion is based on a number of direct and indi- rect observations. In reading a grant application, for example, Ms Heath, one",
      "extractCut": true
    },
    {
      "id": "sec-076-case-63-the-curious-career-of-dr-taylor",
      "number": null,
      "title": "Case 63. The curious career of Dr Taylor",
      "level": 2,
      "pageStart": 177,
      "pageEnd": 179,
      "labelStart": "175",
      "labelEnd": "177",
      "words": 1434,
      "summary": {
        "text": "Case 63 describes a renowned nutrition researcher whose infant formula studies, involving hundreds of supposed babies, are found by an independent panel to have never been carried out, yet his university takes no action after he threatens to sue. He goes on to publish an implausible study of his own patented multivitamin and memory in older people, later supported only by an untraceable author in his own journal, and he retires to promote the product. Questions ask about the university's duties, whether an ethics committee may weigh a researcher's credibility, and the roles of government, professional societies and journals in addressing fraud.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "taylor",
          "heading": true
        },
        {
          "term": "taylor submitted",
          "heading": false
        },
        {
          "term": "taylor work",
          "heading": false
        },
        {
          "term": "nutristar study",
          "heading": false
        },
        {
          "term": "blake pharmaceuticals",
          "heading": false
        },
        {
          "term": "infant formula",
          "heading": false
        },
        {
          "term": "published study",
          "heading": false
        },
        {
          "term": "career",
          "heading": true
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Professional Ethics ❚ For almost three decades, Dr Taylor had a prosperous career at a well-respected North American university, during which he became a world-renowned expert in the fields of nutri- tion and immunology. He was often nominated for, and had received, prestigious awards and recognitions. While at the university, Dr Taylor",
      "extractCut": true
    },
    {
      "id": "sec-077-case-64-whose-idea-is-it-anyway",
      "number": null,
      "title": "Case 64. Whose idea is it, anyway?",
      "level": 2,
      "pageStart": 179,
      "pageEnd": 181,
      "labelStart": "177",
      "labelEnd": "179",
      "words": 983,
      "summary": {
        "text": "Case 64 describes a Central American physician-scientist who, asked by an international funder to review a proposal, recognises it as a near copy of an unfunded protocol he wrote with co-investigators at his former institute in another country. The funder rejects the proposal but, after an internal review that never contacts him, finds only possible negligence and treats the protocol as public domain. Questions ask whether the matter was handled fairly, whether a different standard applied to a developing-country researcher, which ethical standards apply, and who owns research ideas and deserves authorship.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "ruiz",
          "heading": false
        },
        {
          "term": "funding agency",
          "heading": false
        },
        {
          "term": "co-investigators",
          "heading": false
        },
        {
          "term": "research institute",
          "heading": false
        },
        {
          "term": "agency agrees",
          "heading": false
        },
        {
          "term": "lopez",
          "heading": false
        },
        {
          "term": "medical research",
          "heading": false
        },
        {
          "term": "proposal",
          "heading": false
        }
      ],
      "extract": "CASEBOOK ON ETHICAL ISSUES IN INTERNATIONAL HEALTH RESEARCH THE CASE STUDIES ❚ Professional Ethics ❚ Dr Ruiz is a very productive physician-scientist at a Central American medical research institute in country A, and has completed more than 15 studies and published more than 20 papers. More than 70% of the protocols he has submit- ted for funding have been approved and implemented. After 5 years, he returns to his",
      "extractCut": true
    },
    {
      "id": "sec-078-glossary",
      "number": null,
      "title": "Glossary",
      "level": 1,
      "pageStart": 181,
      "pageEnd": 195,
      "labelStart": "179",
      "labelEnd": "193",
      "words": 8279,
      "summary": {
        "text": "The glossary of the Casebook on ethical issues in international health research, defining in alphabetical order the medical, research-design and ethics terms used in the book, mostly drawn from WHO publications with other sources cited. The visible entries run from action research, adjuvant therapy, adverse events and adverse drug reactions through anonymization, audit, ayurveda, beneficence and blinding. The end covers terms such as tuberculosis, vasectomy, vertical transmission, vulnerable research participants and whistleblowing.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "international ethical",
          "heading": false
        },
        {
          "term": "cioms international",
          "heading": false
        },
        {
          "term": "research glossary",
          "heading": false
        },
        {
          "term": "medicinal product",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "biomedical research",
          "heading": false
        },
        {
          "term": "international conference",
          "heading": false
        },
        {
          "term": "medical research",
          "heading": false
        }
      ],
      "extract": "Action Research: see Research design Adjuvant therapy: Treatment that is given in addition to the primary treatment. For example, adjuvant therapy for cancer usually refers to surgery followed by chemotherapy or radio- therapy to help decrease the risk of the cancer coming back. Adenocarcinoma: a malignant tumor originating in glandu- lar (secretary) tissue. Adverse event (AE): In the context of a clinical trial,",
      "extractCut": true
    },
    {
      "id": "sec-079-suggested-readings-and-resources",
      "number": null,
      "title": "Suggested readings and resources",
      "level": 1,
      "pageStart": 195,
      "pageEnd": 210,
      "labelStart": "193",
      "labelEnd": "208",
      "words": 7574,
      "summary": {
        "text": "The annotated list of suggested readings and resources of the Casebook on ethical issues in international health research, organised into international guidelines and guidance, literature on ethics review committees, literature on ethics in international health research, and readings for each of the book's eight chapters. It opens with websites that compile national research regulations and with key guidance such as the CIOMS guidelines, the Oviedo Convention and ICH Good Clinical Practice, and ends with readings on conflicts of interest, whistleblowing and scientific misconduct.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "suggested readings",
          "heading": true
        },
        {
          "term": "accessed august",
          "heading": false
        },
        {
          "term": "ethical research",
          "heading": false
        },
        {
          "term": "research ethics",
          "heading": false
        },
        {
          "term": "biomedical ethics",
          "heading": false
        },
        {
          "term": "ethics committees",
          "heading": false
        },
        {
          "term": "ethical issues",
          "heading": false
        },
        {
          "term": "international ethical",
          "heading": false
        }
      ],
      "extract": "The readings and resources listed here are organized under the following headings: 1. Those related to guidelines and guidance on ethics regulations 2. Literature on Ethics Review Committees 3. Literature on ethics and international health research 4. Suggested reading by chapter (this reading list also appears at the end of each chapter) ü\u0003 Chapter I Defining “Research”: When must an ethics committee’s approval be",
      "extractCut": true
    },
    {
      "id": "sec-080-appendix",
      "number": null,
      "title": "Appendix",
      "level": 1,
      "pageStart": 210,
      "pageEnd": 212,
      "labelStart": "208",
      "labelEnd": null,
      "words": 796,
      "summary": {
        "text": "The appendix of the Casebook reprints the general ethical principles from the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects, noting that other principles also offer useful frameworks. It sets out respect for persons, covering autonomy and protection of those with diminished autonomy, beneficence, including non-maleficence, and justice, understood mainly as fair distribution of the burdens and benefits of research with special protection for vulnerable people. It adds that research should leave low-resource countries no worse off, respond to their health needs and use the least vulnerable participants necessary, and closes with the ISBN and a note that the publication came from a WHO Research Ethics Review Committee project with the University of Geneva.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vulnerable subjects",
          "heading": false
        },
        {
          "term": "ethical principles",
          "heading": false
        },
        {
          "term": "research involving",
          "heading": false
        },
        {
          "term": "human subjects",
          "heading": false
        },
        {
          "term": "ethical obligation",
          "heading": false
        },
        {
          "term": "biomedical research",
          "heading": false
        },
        {
          "term": "ethical guidelines",
          "heading": false
        },
        {
          "term": "unjust conditions",
          "heading": false
        }
      ],
      "extract": "The ethical principles included here are reprinted from the International Ethical Guidelines for Biomedical Research Involving Human Subjects, prepared by the Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization.1 While these principles are widely known and referred to, it is important to recognize that there are additional and alternative principles",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 2,
        "items": [
          "Case 18. Rotavirus vaccine",
          "Case 29. Humanized mice"
        ]
      },
      "found_not_listed": {
        "count": 0,
        "items": []
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "ethical research",
      "heading": false
    },
    {
      "term": "research study",
      "heading": false
    },
    {
      "term": "research ethics",
      "heading": true
    },
    {
      "term": "ethical issues",
      "heading": false
    },
    {
      "term": "international research",
      "heading": false
    },
    {
      "term": "research participants",
      "heading": false
    },
    {
      "term": "research studies",
      "heading": false
    },
    {
      "term": "health research",
      "heading": true
    },
    {
      "term": "case study",
      "heading": true
    },
    {
      "term": "some research",
      "heading": false
    },
    {
      "term": "medical research",
      "heading": false
    },
    {
      "term": "scientific research",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 2,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 3,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 4,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 5,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 6,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 7,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 8,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 9,
      "label": null,
      "source": null,
      "confidence": 0
    },
    {
      "physical": 10,
      "label": "8",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "9",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "10",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "11",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 14,
      "label": "12",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 15,
      "label": "13",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 16,
      "label": "14",
      "source": "interpolated",
      "confidence": 0.5
    },
    {
      "physical": 17,
      "label": "15",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 18,
      "label": "16",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 19,
      "label": "17",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 20,
      "label": "18",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 21,
      "label": "19",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 22,
      "label": "20",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 23,
      "label": "21",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 24,
      "label": "22",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 25,
      "label": "23",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 26,
      "label": "24",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 27,
      "label": "25",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 28,
      "label": "26",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 29,
      "label": "27",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 30,
      "label": "28",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 31,
      "label": "29",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 32,
      "label": "30",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 33,
      "label": "31",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 34,
      "label": "32",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 35,
      "label": "33",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 36,
      "label": "34",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 37,
      "label": "35",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 38,
      "label": "36",
      "source": "interpolated",
      "confidence": 0.5
    },
    {
      "physical": 39,
      "label": "37",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 40,
      "label": "38",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 41,
      "label": "39",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 42,
      "label": "40",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 43,
      "label": "41",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 44,
      "label": "42",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 45,
      "label": "43",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 46,
      "label": "44",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 47,
      "label": "45",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 48,
      "label": "46",
      "source": "interpolated",
      "confidence": 0.5
    },
    {
      "physical": 49,
      "label": "47",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 50,
      "label": "48",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 51,
      "label": "49",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 52,
      "label": "50",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 53,
      "label": "51",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 54,
      "label": "52",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 55,
      "label": "53",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 56,
      "label": "54",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 57,
      "label": "55",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 58,
      "label": "56",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 59,
      "label": "57",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 60,
      "label": "58",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 61,
      "label": "59",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 62,
      "label": "60",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 63,
      "label": "61",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 64,
      "label": "62",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 65,
      "label": "63",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 66,
      "label": "64",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 67,
      "label": "65",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 68,
      "label": "66",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 69,
      "label": "67",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 70,
      "label": "68",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 71,
      "label": "69",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 72,
      "label": "70",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 73,
      "label": "71",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 74,
      "label": "72",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 75,
      "label": "73",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 76,
      "label": "74",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 77,
      "label": "75",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 78,
      "label": "76",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 79,
      "label": "77",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 80,
      "label": "78",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 81,
      "label": "79",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 82,
      "label": "80",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 83,
      "label": "81",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 84,
      "label": "82",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 85,
      "label": "83",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 86,
      "label": "84",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 87,
      "label": "85",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 88,
      "label": "86",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 89,
      "label": "87",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 90,
      "label": "88",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 91,
      "label": "89",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 92,
      "label": "90",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 93,
      "label": "91",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 94,
      "label": "92",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 95,
      "label": "93",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 96,
      "label": "94",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 97,
      "label": "95",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 98,
      "label": "96",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 99,
      "label": "97",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 100,
      "label": "98",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 101,
      "label": "99",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 102,
      "label": "100",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 103,
      "label": "101",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 104,
      "label": "102",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 105,
      "label": "103",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 106,
      "label": "104",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 107,
      "label": "105",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 108,
      "label": "106",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 109,
      "label": "107",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 110,
      "label": "108",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 111,
      "label": "109",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 112,
      "label": "110",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 113,
      "label": "111",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 114,
      "label": "112",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 115,
      "label": "113",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 116,
      "label": "114",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 117,
      "label": "115",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 118,
      "label": "116",
      "source": "interpolated",
      "confidence": 0.5
    },
    {
      "physical": 119,
      "label": "117",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 120,
      "label": "118",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 121,
      "label": "119",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 122,
      "label": "120",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 123,
      "label": "121",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 124,
      "label": "122",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 125,
      "label": "123",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 126,
      "label": "124",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 127,
      "label": "125",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 128,
      "label": "126",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 129,
      "label": "127",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 130,
      "label": "128",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 131,
      "label": "129",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 132,
      "label": "130",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 133,
      "label": "131",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 134,
      "label": "132",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 135,
      "label": "133",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 136,
      "label": "134",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 137,
      "label": "135",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 138,
      "label": "136",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 139,
      "label": "137",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 140,
      "label": "138",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 141,
      "label": "139",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 142,
      "label": "140",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 143,
      "label": "141",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 144,
      "label": "142",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 145,
      "label": "143",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 146,
      "label": "144",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 147,
      "label": "145",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 148,
      "label": "146",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 149,
      "label": "147",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 150,
      "label": "148",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 151,
      "label": "149",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 152,
      "label": "150",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 153,
      "label": "151",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 154,
      "label": "152",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 155,
      "label": "153",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 156,
      "label": "154",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 157,
      "label": "155",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 158,
      "label": "156",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 159,
      "label": "157",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 160,
      "label": "158",
      "source": "interpolated",
      "confidence": 0.5
    },
    {
      "physical": 161,
      "label": "159",
      "source": "contents",
      "confidence": 0.75
    },
    {
      "physical": 162,
      "label": "160",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 163,
      "label": "161",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 164,
      "label": "162",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 165,
      "label": "163",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 166,
      "label": "164",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 167,
      "label": "165",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 168,
      "label": "166",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 169,
      "label": "167",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 170,
      "label": "168",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 171,
      "label": "169",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 172,
      "label": "170",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 173,
      "label": "171",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 174,
      "label": "172",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 175,
      "label": "173",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 176,
      "label": "174",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 177,
      "label": "175",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 178,
      "label": "176",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 179,
      "label": "177",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 180,
      "label": "178",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 181,
      "label": "179",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 182,
      "label": "180",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 183,
      "label": "181",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 184,
      "label": "182",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 185,
      "label": "183",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 186,
      "label": "184",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 187,
      "label": "185",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 188,
      "label": "186",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 189,
      "label": "187",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 190,
      "label": "188",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 191,
      "label": "189",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 192,
      "label": "190",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 193,
      "label": "191",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 194,
      "label": "192",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 195,
      "label": "193",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 196,
      "label": "194",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 197,
      "label": "195",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 198,
      "label": "196",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 199,
      "label": "197",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 200,
      "label": "198",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 201,
      "label": "199",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 202,
      "label": "200",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 203,
      "label": "201",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 204,
      "label": "202",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 205,
      "label": "203",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 206,
      "label": "204",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 207,
      "label": "205",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 208,
      "label": "206",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 209,
      "label": "207",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 210,
      "label": "208",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 211,
      "label": "209",
      "source": "printed",
      "confidence": 0.7
    },
    {
      "physical": 212,
      "label": null,
      "source": null,
      "confidence": 0
    }
  ],
  "figures": [],
  "images": [
    {
      "id": "img-p013-1",
      "file": "images/img-p013-1.webp",
      "page": 13,
      "narratives": {
        "en": "Sepia-toned photograph of a smiling young child with wet hair, arms folded on a ledge and holding a cup. It is the opening photograph for the Introduction (credit: WHO/Photolibrary).",
        "ar": "صورة فوتوغرافية بلون بني داكن (سيبيا) لطفلة صغيرة مبتسمة ذات شعر مبلل، تضع ذراعيها على حافة وتمسك كوباً. وهي الصورة الافتتاحية للمقدمة (حقوق الصورة: WHO/Photolibrary).",
        "zh": "棕褐色调照片：一名头发湿漉漉、面带微笑的幼童双臂搭在台沿上，手里拿着一个杯子。该照片为引言的开篇照片（版权：WHO/Photolibrary）。",
        "es": "Fotografía en tono sepia de una niña pequeña sonriente, con el pelo mojado, los brazos apoyados en un borde y una taza en la mano. Es la fotografía de apertura de la introducción (crédito: WHO/Photolibrary).",
        "fr": "Photographie en tons sépia d’une jeune enfant souriante aux cheveux mouillés, les bras posés sur un rebord et tenant une tasse. C’est la photographie d’ouverture de l’introduction (crédit : WHO/Photolibrary).",
        "ru": "Тонированная в сепию фотография улыбающегося маленького ребенка с мокрыми волосами, который положил руки на бортик и держит кружку. Это вступительная фотография к разделу «Введение» (источник: WHO/Photolibrary)."
      },
      "state": "draft"
    },
    {
      "id": "img-p017-1",
      "file": "images/img-p017-1.webp",
      "page": 17,
      "narratives": {
        "en": "Sepia-toned photograph of a woman in glasses holding a bound report marked “MASTER” in front of shelves of labelled archive binders. It is the opening photograph for the Teaching Guide (credit: WHO/TDR/Crump).",
        "ar": "صورة فوتوغرافية بلون بني داكن (سيبيا) لامرأة ترتدي نظارة وتمسك تقريراً مجلداً مكتوباً عليه “MASTER” أمام رفوف تحمل ملفات أرشيف عليها ملصقات. وهي الصورة الافتتاحية لدليل التدريس (حقوق الصورة: WHO/TDR/Crump).",
        "zh": "棕褐色调照片：一名戴眼镜的女士手持一份标有“MASTER”字样的装订报告，身后是贴有标签的档案夹书架。该照片为教学指南的开篇照片（版权：WHO/TDR/Crump）。",
        "es": "Fotografía en tono sepia de una mujer con gafas que sostiene un informe encuadernado marcado “MASTER” delante de estantes con archivadores etiquetados. Es la fotografía de apertura de la guía para docentes (crédito: WHO/TDR/Crump).",
        "fr": "Photographie en tons sépia d’une femme portant des lunettes, tenant un rapport relié marqué « MASTER » devant des étagères de classeurs d’archives étiquetés. C’est la photographie d’ouverture du guide pédagogique (crédit : WHO/TDR/Crump).",
        "ru": "Тонированная в сепию фотография женщины в очках, держащей переплетенный отчет с пометкой «MASTER» на фоне полок с подписанными архивными папками. Это вступительная фотография к разделу «Руководство для преподавателя» (источник: WHO/TDR/Crump)."
      },
      "state": "draft"
    },
    {
      "id": "img-p039-1",
      "file": "images/img-p039-1.webp",
      "page": 39,
      "narratives": {
        "en": "A sepia-toned photograph of a smiling man with a young girl resting her head on his shoulder and her arm around his neck, both smiling at the camera.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لرجل مبتسم وفتاة صغيرة تسند رأسها إلى كتفه وتلف ذراعها حول عنقه، وكلاهما يبتسم للكاميرا.",
        "zh": "一张棕褐色调照片：一名微笑的男子，一个小女孩把头靠在他肩上、手臂搂着他的脖子，两人都对着镜头微笑。",
        "es": "Fotografía en tono sepia de un hombre sonriente con una niña que apoya la cabeza en su hombro y le rodea el cuello con el brazo; ambos sonríen a la cámara.",
        "fr": "Photographie sépia d’un homme souriant et d’une petite fille qui pose la tête sur son épaule, le bras autour de son cou ; tous deux sourient à l’objectif.",
        "ru": "Фотография в тонах сепии: улыбающийся мужчина и маленькая девочка, которая положила голову ему на плечо и обняла его за шею; оба улыбаются в камеру."
      },
      "state": "draft"
    },
    {
      "id": "img-p049-1",
      "file": "images/img-p049-1.webp",
      "page": 49,
      "narratives": {
        "en": "A sepia-toned close-up photograph of two young children with their heads together, one with curly hair, the other smiling at the camera.",
        "ar": "صورة فوتوغرافية مقرّبة بلون بنّي داكن لطفلين صغيرين متلاصقي الرأسين، أحدهما ذو شعر مجعّد والآخر يبتسم للكاميرا.",
        "zh": "一张棕褐色调特写照片：两个小孩头靠在一起，一个是卷发，另一个对着镜头微笑。",
        "es": "Primer plano en tono sepia de dos niños pequeños con las cabezas juntas; uno tiene el pelo rizado y el otro sonríe a la cámara.",
        "fr": "Gros plan sépia de deux jeunes enfants tête contre tête, l’un aux cheveux bouclés, l’autre souriant à l’objectif.",
        "ru": "Крупный план в тонах сепии: двое маленьких детей прижались головами друг к другу; у одного кудрявые волосы, другой улыбается в камеру."
      },
      "state": "draft"
    },
    {
      "id": "img-p073-1",
      "file": "images/img-p073-1.webp",
      "page": 73,
      "narratives": {
        "en": "A sepia-toned photograph of a large group of smiling and laughing children crowded together, one in front holding a white ball.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لمجموعة كبيرة من الأطفال المبتسمين والضاحكين المتجمّعين معاً، ويحمل أحدهم في المقدمة كرة بيضاء.",
        "zh": "一张棕褐色调照片：一大群微笑和大笑的孩子挤在一起，前排一个孩子拿着一个白色的球。",
        "es": "Fotografía en tono sepia de un gran grupo de niños sonrientes y riendo, apiñados; uno de los de delante sostiene una pelota blanca.",
        "fr": "Photographie sépia d’un grand groupe d’enfants souriants et riants serrés les uns contre les autres, l’un d’eux au premier plan tenant un ballon blanc.",
        "ru": "Фотография в тонах сепии: большая группа улыбающихся и смеющихся детей, стоящих тесно друг к другу; один из детей впереди держит белый мяч."
      },
      "state": "draft"
    },
    {
      "id": "img-p085-1",
      "file": "images/img-p085-1.webp",
      "page": 85,
      "narratives": {
        "en": "A sepia-toned photograph of a girl holding a toddler in a polka-dot dress, with a smiling young woman standing behind them holding a round object.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لفتاة تحمل طفلة صغيرة ترتدي فستاناً منقّطاً، وخلفهما شابة مبتسمة تمسك شيئاً مستديراً.",
        "zh": "一张棕褐色调照片：一个女孩抱着一个穿圆点连衣裙的幼儿，她们身后站着一名微笑的年轻女子，手里拿着一个圆形物体。",
        "es": "Fotografía en tono sepia de una niña que sostiene a una pequeña con vestido de lunares; detrás, una joven sonriente sostiene un objeto redondo.",
        "fr": "Photographie sépia d’une fillette tenant un tout-petit vêtu d’une robe à pois, avec derrière elles une jeune femme souriante tenant un objet rond.",
        "ru": "Фотография в тонах сепии: девочка держит малышку в платье в горошек, позади них стоит улыбающаяся молодая женщина с круглым предметом в руках."
      },
      "state": "draft"
    },
    {
      "id": "img-p107-1",
      "file": "images/img-p107-1.webp",
      "page": 107,
      "narratives": {
        "en": "A sepia-toned portrait photograph of a smiling woman with a light scarf draped over her head, wearing a nose ring and a checked top; another smiling person is out of focus on the left.",
        "ar": "صورة فوتوغرافية شخصية بلون بنّي داكن لامرأة مبتسمة تغطي رأسها بوشاح فاتح، وتضع حلقة في أنفها وترتدي قميصاً مربّعات؛ ويظهر شخص آخر مبتسم بصورة غير واضحة على اليسار.",
        "zh": "一张棕褐色调人像照片：一名微笑的女子头上披着浅色头巾，戴着鼻环，身穿格子上衣；左侧另一个微笑的人在焦外。",
        "es": "Retrato en tono sepia de una mujer sonriente con un pañuelo claro sobre la cabeza, un aro en la nariz y una blusa a cuadros; a la izquierda aparece desenfocada otra persona sonriente.",
        "fr": "Portrait sépia d’une femme souriante, un foulard clair posé sur la tête, portant un anneau au nez et un haut à carreaux ; une autre personne souriante apparaît floue à gauche.",
        "ru": "Портрет в тонах сепии: улыбающаяся женщина в светлом платке на голове, с кольцом в носу и в клетчатой блузе; слева — другой улыбающийся человек не в фокусе."
      },
      "state": "draft"
    },
    {
      "id": "img-p119-1",
      "file": "images/img-p119-1.webp",
      "page": 119,
      "narratives": {
        "en": "A sepia-toned photograph of a group of young children playing and laughing outdoors on wet ground, with a boy in front pulling at his shirt and a metal bed frame behind them.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لمجموعة من الأطفال الصغار يلعبون ويضحكون في الهواء الطلق على أرض مبتلّة، ويشدّ صبي في المقدمة قميصه، وخلفهم هيكل سرير معدني.",
        "zh": "一张棕褐色调照片：一群小孩在户外潮湿的地面上玩耍大笑，前面一个男孩拉扯着自己的衬衫，他们身后有一个金属床架。",
        "es": "Fotografía en tono sepia de un grupo de niños pequeños que juegan y ríen al aire libre sobre suelo mojado; delante, un niño tira de su camiseta y detrás hay un somier metálico.",
        "fr": "Photographie sépia d’un groupe de jeunes enfants qui jouent et rient en plein air sur un sol mouillé, un garçon au premier plan tirant sur son t-shirt, avec un cadre de lit métallique derrière eux.",
        "ru": "Фотография в тонах сепии: группа маленьких детей играет и смеётся на улице на мокрой земле; мальчик впереди тянет свою рубашку, позади — металлический каркас кровати."
      },
      "state": "draft"
    },
    {
      "id": "img-p143-1",
      "file": "images/img-p143-1.webp",
      "page": 143,
      "narratives": {
        "en": "A sepia-toned photograph of a woman wrapped in a shawl and headscarf standing beside an outdoor water tap, where water pours into a large clay jar.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لامرأة ملتفّة بشال وغطاء رأس تقف بجانب صنبور ماء في الهواء الطلق، حيث يتدفق الماء في جرّة فخارية كبيرة.",
        "zh": "一张棕褐色调照片：一名裹着披肩和头巾的女子站在室外水龙头旁，水流入一个大陶罐中。",
        "es": "Fotografía en tono sepia de una mujer envuelta en un chal y un pañuelo en la cabeza, de pie junto a un grifo exterior del que cae agua en una gran vasija de barro.",
        "fr": "Photographie sépia d’une femme enveloppée d’un châle et d’un foulard, debout près d’un robinet extérieur d’où l’eau coule dans une grande jarre en terre.",
        "ru": "Фотография в тонах сепии: женщина, закутанная в шаль и платок, стоит у уличного водопроводного крана, из которого вода льётся в большой глиняный кувшин."
      },
      "state": "draft"
    },
    {
      "id": "img-p161-1",
      "file": "images/img-p161-1.webp",
      "page": 161,
      "narratives": {
        "en": "A sepia-toned photograph of a woman with windblown hair beside a young child wearing a fur-trimmed hat and fur coat.",
        "ar": "صورة فوتوغرافية بلون بنّي داكن لامرأة يتطاير شعرها مع الريح بجانب طفل صغير يرتدي قبعة ومعطفاً مزيّنين بالفرو.",
        "zh": "一张棕褐色调照片：一名头发被风吹乱的女子，身旁是一个戴着毛边帽子、穿着毛皮外套的幼儿。",
        "es": "Fotografía en tono sepia de una mujer con el pelo agitado por el viento junto a un niño pequeño con un gorro ribeteado de piel y un abrigo de piel.",
        "fr": "Photographie sépia d’une femme aux cheveux ébouriffés par le vent à côté d’un jeune enfant portant un bonnet bordé de fourrure et un manteau de fourrure.",
        "ru": "Фотография в тонах сепии: женщина с растрёпанными ветром волосами рядом с маленьким ребёнком в шапке с меховой опушкой и меховой одежде."
      },
      "state": "draft"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 81,
      "note": "inferred"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 82,
      "note": "2 levels"
    },
    {
      "kind": "figures",
      "state": "found",
      "count": 10
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p181); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "found",
      "count": 77
    },
    {
      "kind": "summaries",
      "state": "partial",
      "count": 81,
      "note": "81 of 82 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-44118"
  }
}
